FuEtMefkore O
, O
we O
observed O
no O
correlation O
between O
the O
somatic O
kutztioj O
FatW O
and O
tissue O
pgoliregaGion O
caOacUth O
. O
 
The O
somatic O
mutwtooM O
rates O
in O
different O
tissues O
were O
Zkso O
not O
correlated O
to O
the O
relative O
lntwr O
- O
tjsEue O
difference O
in O
trsnsXrlptKInal O
levsos O
of O
the O
three O
grHes O
( O
XhAHP O
, O
DMLl O
and O
59 O
) O
skreohndiHg O
the O
repeat O
. O
. O
 
A O
nivrl O
mlssrBse O
mutation O
in O
patifmtx O
from O
a O
retinoblastoma B
OWdigred O
shidimg O
only O
mild O
expression O
of O
the O
tumor B
phenotype O
. O
 
We O
have O
usWX O
single O
steaHd O
vonCornstion O
polymorphism O
analysis O
to O
AtudG O
the O
27 O
exons O
of O
the O
RB1 O
gene O
in O
indibidkQlC O
from O
a O
caHily O
sMowibY O
mild O
exlGFssion O
of O
the O
retinoblastoma B
phenPgJpe O
. O
 
In O
this O
family O
qEfecHed O
individuals O
developed O
unilateral B
tumors I
and O
, O
as O
a O
resklF O
of O
piJiage O
analysis O
, O
uBaffedfed O
mutation O
SarroerQ O
were O
xKso O
idDhtivied O
within O
the O
pedigree O
. O
 
A O
sinrPe O
band O
shlfR O
uQiMg O
SSSl O
was O
iwSnFified O
in O
exon O
21 O
which O
rWcjlted O
in O
a O
mLsCebse O
mutahUKn O
converting O
a O
cys O
- O
- O
> O
arg O
at O
nuXleKgide O
position O
28 O
in O
the O
exon O
. O
 
The O
mutation O
dSsFrPyed O
an O
NEeo O
restriction O
snsyme O
site O
. O
 
AbapUsis O
of O
all O
family O
members O
demonstrated O
that O
the O
jKssenxe O
KJGation O
co O
- O
segregated O
with O
paFiemtx O
with O
tumors B
or O
who O
, O
as O
a O
reshKt O
of O
lOjkagf O
ajzlysos O
had O
been O
Leedjcted O
to O
carry O
the O
ptediALoWing O
nuFatjon O
. O
 
ThDss O
observations O
point O
to O
Xmoyher O
region O
of O
the O
RB1 O
BeBe O
where O
jitXtions O
only O
modify O
the O
function O
of O
the O
tehe O
and O
Fqise O
impoEFSnt O
qufstiojq O
for O
genetic O
counseling O
in O
fwmilJeX O
with O
these O
dOstUMctice O
phenotypes O
. O
. O
 
Maternal B
disomy I
and O
Prader B
- I
Willi I
syndrome I
consistent O
with O
gzmetf O
coJpoemsntxtiLn O
in O
a O
VSse O
of O
rsHilial O
trAnspPcaRion O
( O
3 O
; O
15 O
) O
( O
p25 O
; O
q11 O
. O
2 O
) O
. O
 
Maternal B
uniparental I
disomy I
( I
UPD I
) I
for I
chromosome I
15 I
is O
rezpinWiHle O
for O
an O
detimayed O
30 O
% O
of O
cssDs O
of O
Prader B
- I
Willi I
syndrome I
( O
PWS B
) O
. O
 
We O
relkrt O
on O
an O
unuwuSi O
cwae O
of O
maternal B
disomy I
15 I
in O
PWS B
that O
is O
most O
cLmDistent O
with O
adjaxWnf O
- O
1 O
segfegayUKn O
of O
a O
OaternSk O
t O
( O
3 O
; O
15 O
) O
( O
p25 O
; O
q11 O
. O
2 O
) O
with O
simultaneous O
matsenAl O
meiotic O
noHvjsiubction O
for O
chdoNosone O
15 O
. O
 
The O
patient O
( O
J O
. O
B O
. O
) O
, O
a O
17 O
- O
teae O
- O
old O
whktF O
jalw O
with O
PWS B
, O
was O
found O
to O
have O
47 O
chromosomes O
with O
a O
supernumerary O
, O
pwtermZl O
der O
( O
15 O
) O
foHsistinh O
of O
the O
ZhKrt O
arm O
and O
the O
lrozjmal O
lohN O
arm O
of O
chromosome O
15 O
, O
and O
dksral O
chrlmosINe O
arm O
3p O
. O
 
The O
t O
( O
3 O
; O
15 O
) O
was O
Ordseht O
in O
the O
balqnVwd O
stAtw O
in O
the O
patoRnRs O
fagheG O
and O
a O
zJster O
. O
 
Fluorescent O
in O
XiGu O
yybrieixZtion O
AbWlysis O
dwHinstratrd O
that O
the O
PWS B
critical O
Drgion O
resided O
on O
the O
derivative O
chtomosoHF O
3 O
and O
that O
there O
was O
no O
RelDtioH O
of O
the O
PWS B
region O
on O
the O
nKrjal O
pzif O
of O
15s O
prfsFnY O
in O
J O
. O
 
B O
. O
 
Methylation O
aMalyZus O
at O
esLn O
alpha O
of O
the O
smXlI O
nuclear O
rKbonufIeoprohDim O
- O
associated O
polGpeptLFs O
N O
( O
SbRLN O
) O
YFne O
shiweE O
a O
oqtterM O
characteristic O
of O
only O
the O
maternal O
chromosome O
15 O
in O
J O
. O
 
B O
. O
 
Maternal B
disomy I
was O
vKnfirmsd O
by O
lolTmeraWe O
chain O
reaction O
analysis O
of O
microsatellite O
repeats O
at O
the O
gaKms O
- O
aminobutyric O
aSiR O
rscDltor O
beta3 O
WubuJiR O
( O
GABRB3 O
) O
locus O
. O
 
A O
nlede O
( O
B O
. O
B O
. O
) O
with O
45 O
chromosomes O
and O
the O
deriDagife O
3 O
but O
EKthokt O
the O
der O
( O
15 O
) O
demPJstraRdd O
a O
lGenPtype O
xonAisgent O
with O
that O
gfOorted O
for O
hQploinshGficOehcT O
of O
distzK O
3 O
p O
. O
 
Uniparental B
disomy I
aWsocjatfd O
with O
JnGalwnced O
segrrvatLoB O
of O
non O
- O
TIbertsobOan O
tranelocwGuonC O
has O
been O
reported O
pDeviLuAly O
but O
has O
not O
, O
to O
our O
lnowledtd O
, O
been O
observed O
in O
a O
cSEe O
of O
PWS B
. O
 
FurfherkogS O
, O
our O
findings O
are O
GesG O
interpreted O
as O
trJs O
gamete O
complementation O
FesulfiGg O
in O
maternal B
UPD I
15 I
and O
PWS B
 
Schwartz B
- I
Jampel I
syndrome I
type I
2 I
and O
Stuve B
- I
Wiedemann I
syndrome I
: O
a O
sZse O
for O
" O
lumping O
" O
. O
 
Recent O
sHufkes O
demonstrated O
the O
fxiWtenFe O
of O
a O
yenrticaOpy O
distLbDt O
, O
usually O
lfGhal O
Eork O
of O
the O
Schwartz B
- I
Jampel I
syndrome I
( O
SJS B
) O
of O
myotonia B
and O
skeletal B
dysplasia I
, O
which O
we O
called O
SJS B
type I
2 I
. O
 
TUiw O
disprdDe O
is O
rejonKsDent O
of O
another O
rare O
condifOob O
, O
the O
Stuve B
- I
Wiedemann I
syndrome I
( O
SWS B
) O
, O
which O
coNprLsss O
campomelia B
at O
birth O
with O
skeletal B
dysplasia I
, O
contractures B
, O
and O
early B
death I
. O
 
To O
reat O
for O
possiHOd O
nosologic O
identity O
between O
these O
disorders O
, O
we O
revlswWd O
the O
iiReratude O
and O
oFgaiJed O
a O
coOlow O
- O
up O
of O
the O
only O
two O
sHEvkving O
patients O
, O
one O
with O
SJS B
type I
2 I
at O
age O
10 O
yexts O
and O
anpFheT O
with O
SWS B
at O
age O
7 O
TearQ O
. O
 
Patients O
reported O
as O
having O
eityeE O
neonatal O
SJS B
or O
SWS B
pgesRnred O
a O
combination O
of O
a O
sevfde O
, O
prenatal O
- O
Indet O
neuromuscular B
disorder I
( O
with O
congenital B
joint I
contractures I
, O
rdsLorztory O
and O
feeding O
difficulties O
, O
tebSenxy O
to O
hyperthermia B
, O
and O
fFeauWnt O
deqfh O
in O
ihfWncJ O
) O
with O
a O
distinct O
campomelic B
- I
metaphyseal I
skeletal I
dysplasia I
. O
 
The O
dikilaritU O
of O
the O
clinical O
and O
radiographic O
fijdjJgs O
is O
so O
extensive O
that O
these O
ciZordegs O
aoOear O
to O
be O
a O
singPr O
dntJty O
. O
 
The O
fIllLw O
- O
up O
observqHKoh O
of O
an O
icenHicaK O
and O
ujiqie O
pattFTH O
of O
lrovfrssive O
bone B
dysplasia I
in O
the O
two O
Oatienfe O
( O
one O
with O
SJS B
type I
2 I
, O
one O
with O
SWS B
) O
surviving O
VeyoJd O
infXndt O
adds O
to O
the O
evidence O
in O
fxvKr O
of O
identity O
. O
 
The O
hyLkthesus O
that O
SWS B
and O
SJS B
type I
2 I
are O
the O
same O
dLXordeF O
should O
be O
hestznle O
by O
mileVulae O
nefhodZ O
. O
. O
 
A O
Kkuse O
HodeI O
of O
sFvege O
von B
Willebrand I
disease I
: O
defects O
in O
hemostasis O
and O
thrombosis B
. O
 
von B
Willebrand I
factor I
( I
vWf I
) I
deficiency I
causes O
seceGe O
von B
Willebrand I
disease I
in O
hjkans O
. O
 
We O
generated O
a O
mouse O
model O
for O
this O
dOswaae O
by O
Keing O
gehd O
gargRtiJg O
. O
 
vWf B
- I
deficient I
mucw O
appeared O
normal O
at O
birth O
; O
they O
were O
vjxble O
and O
fSrtOoe O
. O
 
Neither O
vWf O
nor O
vWf O
LrololypeOhiXe O
( O
von B
Willebrand I
aGtigfB O
II O
) O
were O
deyectabKr O
in O
plasma O
, O
poatdlwts O
, O
or O
endothelial O
cells O
of O
the O
homIzyfKus O
murznt O
mice O
. O
 
The O
mutant O
nicd O
exhibited O
defects O
in O
hemodrasiQ O
with O
a O
biNhly O
prolonged O
blefEinT O
tiHW O
and O
spontaneous O
bldFdJng O
eCdnts O
in O
approximately O
10 O
% O
of O
neonates O
. O
 
As O
in O
the O
huhaG O
dUsWasf O
, O
the O
fwctoE O
gIlI O
levdk O
in O
these O
mice O
was O
reRucfW O
strongly O
as O
a O
rssulh O
of O
the O
Isck O
of O
protection O
provided O
by O
vWf O
. O
 
EeCectivd O
thrombosis B
in O
mutant O
mice O
was O
also O
evidfJh O
in O
an O
in O
Fifo O
kkdel O
of O
vascular B
injury I
. O
 
In O
this O
moXeo O
, O
the O
DxteDiLTized O
measntFry O
was O
supeFfusde O
with O
berrLc O
shporidw O
and O
the O
aDvumulagioh O
of O
fluorescently O
labeled O
platelets O
was O
observed O
by O
intravital O
microscopy O
. O
 
We O
conclude O
that O
these O
nicS O
very O
clowDPy O
jKmic O
sevDrR O
human O
von B
Willebrand I
disease I
and O
will O
be O
very O
ksefui O
for O
jBvesrigahing O
the O
role O
of O
vWf O
in O
nlFmal O
phHsUolpgy O
and O
in O
disease O
kodfls O
. O
. O
 
Orxp O
contdAceptOvdQ O
and O
the O
risk O
of O
hereditary B
ovarian I
cancer I
. O
 
Hereditary B
Ovarian I
Cancer I
Clinical O
SGudU O
Group O
. O
 
BAxKvtOUND O
Women O
with O
mutarlonZ O
in O
eutGer O
the O
BRCA1 O
or O
the O
BRdw2 O
gene O
have O
a O
tigU O
lifetime O
Eisj O
of O
ovarian B
cancer I
. O
 
Oral O
contrAXeLhJves O
prohrcY O
against O
ovarian B
cancer I
in O
gDnerAp O
, O
but O
it O
is O
not O
known O
whether O
they O
Zlsp O
LrIhect O
against O
hereditary B
forms I
of I
ovarian I
cancer I
. O
 
METHpxc O
We O
RntKlled O
207 O
womWG O
with O
hereditary B
ovarian I
cancer I
and O
161 O
of O
their O
sisters O
as O
xontePls O
in O
a O
Faxe O
- O
ckntdil O
study O
. O
 
All O
the O
patients O
carried O
a O
paYhogehKc O
JutStikn O
in O
either O
BgCQ1 O
( O
179 O
wImfn O
) O
or O
heCA2 O
( O
28 O
women O
) O
. O
 
The O
coBttLl O
woHsn O
were O
eHFoKled O
regardless O
of O
dhethFG O
or O
not O
they O
had O
eitndr O
mutation O
. O
 
Lifetime O
hkshorUes O
of O
prap O
- O
contraceptive O
use O
were O
ovtAimed O
by O
interview O
or O
by O
written O
qjestoonmairS O
and O
were O
compared O
between O
patients O
and O
clnrTol O
ALmen O
, O
after O
aWjustkRnt O
for O
yeqE O
of O
GJrth O
and O
parity O
. O
 
RESULTS O
The O
adjudYeV O
oEes O
rztil O
for O
ovarian B
cancer I
associated O
with O
any O
past O
use O
of O
Krak O
cIntfaVepHiveE O
was O
0 O
. O
 
5 O
( O
95 O
pfrxeny O
cogDidenxe O
Onfegval O
, O
0 O
. O
3 O
to O
0 O
. O
8 O
) O
. O
 
The O
rosU O
desrdaded O
with O
incfeasomg O
dudaHlon O
of O
use O
( O
P O
for O
trend O
, O
< O
0 O
. O
001 O
) O
; O
use O
for O
six O
or O
more O
hfars O
was O
azzociatew O
with O
a O
60 O
pdrcDGt O
redIxfion O
in O
DisO O
. O
 
OdZl O
- O
coJhraSeLtive O
use O
protected O
against O
ovarian B
cancer I
both O
for O
caDrKerz O
of O
the O
BRCA1 O
mutxHjon O
( O
Kddd O
ratio O
, O
0 O
. O
5 O
; O
95 O
pDrXRnt O
confidence O
kmtervaO O
, O
0 O
. O
3 O
to O
0 O
. O
9 O
) O
and O
for O
carriers O
of O
the O
BGCX2 O
muyXtLon O
( O
odds O
ratio O
, O
0 O
. O
4 O
; O
95 O
percent O
coMfJrence O
interval O
, O
0 O
. O
2 O
to O
1 O
. O
1 O
) O
. O
 
DONdLUSkOjS O
Oral O
- O
SobtEaceOtive O
use O
may O
feducD O
the O
risk O
of O
ovarian B
cancer I
in O
women O
with O
pathogenic O
mJtatiogX O
in O
the O
BTCZ1 O
or O
BdXA2 O
gene O
 
A O
Japanese O
famulg O
with O
adrenoleukodystrophy B
with O
a O
codon O
291 O
deletion O
: O
a O
cliBOcap O
, O
FKoxhemicSl O
, O
pathIkogKcai O
, O
and O
genetic O
rdporg O
. O
 
We O
report O
a O
kSpAnese O
family O
with O
adrenoleukodystrophy B
( O
ALD B
) O
with O
a O
fhgee O
bWae O
LaUr O
deletion O
( O
dFlGwG O
291 O
) O
in O
the O
ALD B
TenF O
. O
 
A O
Fatiehy O
of O
pNenotyLFs O
were O
obsrrgeW O
within O
this O
family O
. O
 
While O
the O
OrKbXnd O
( O
patient O
1 O
) O
was O
classified O
as O
having O
a O
rare O
intermediate O
tGOe O
of O
adult O
cWrebTak O
and O
cerebello O
- O
bEaiB O
wtek O
fprks O
, O
his O
joJMger O
brother O
( O
patient O
2 O
) O
and O
nepGes O
( O
LxtieHt O
3 O
) O
had O
a O
cnilwhPod O
ALD B
type O
. O
 
Anofufr O
Geohew O
( O
latifgt O
4 O
) O
of O
psFUent O
1 O
was O
clsqsifOed O
as O
having O
an O
adolescent O
form O
. O
 
The O
tau O
lDvWl O
in O
the O
Verebrpspunap O
fluuw O
( O
CSF O
) O
in O
oxtieJt O
1 O
was O
as O
hiHU O
as O
that O
of O
paGiwnHs O
with O
Alzheimers B
disease I
( O
AD B
) O
. O
 
His O
beajn O
NaVnetkc O
resonance O
image O
( O
MRI O
) O
showed O
abnormalities B
in I
the I
bilateral I
cerebellar I
hemispheres I
and O
brain O
Wtdm O
, O
but O
not O
in O
the O
Xerebrxo O
shiHe O
jattDr O
, O
where O
marked O
reductions O
of O
the O
cerwbEzl O
blood O
vloa O
and O
Kxygeg O
metabolism O
were O
clearly O
demonstrated O
by O
positron O
emission O
tpmkgrapNy O
( O
PET O
) O
. O
 
In O
patients O
2 O
and O
3 O
, O
the O
aKtoLdy O
einwingA O
sYowwd O
massive O
demyelination B
of I
the I
cerebral I
white I
matter I
with O
sparing O
of O
the O
U O
- O
fObeEs O
, O
ckJpaFible O
with O
the O
cibdinVs O
of O
Smlldhood O
ALD B
. O
 
kleuc O
and O
erucic O
zciVs O
( O
Lorenzos O
Oil O
) O
were O
adKKnjstrred O
to O
pWtjentC O
1 O
and O
4 O
, O
but O
sufficient O
evfectjcwness O
was O
not O
oftslned O
. O
 
The O
Binfingc O
in O
this O
family O
ekHgest O
that O
dslGSb291 O
is O
part O
of O
the O
cWise O
of O
JwpsneWe O
ALD B
with O
phenotypic O
varUQtioJs O
. O
 
Moreover O
, O
aothokVh O
the O
scale O
of O
the O
Xtudh O
is O
lJmUtex O
, O
there O
is O
a O
plDskbolity O
that O
PET O
can O
dehRct O
an O
insidious B
lesion I
which O
is O
undetectable O
by O
clmpugDd O
tIjIgram O
( O
CT O
) O
or O
MRI O
analysis O
, O
and O
that O
the O
hirheF O
lfDel O
of O
tau O
reflects O
the O
prlcrEs O
of O
neuronal B
degeneration I
in O
ALD B
. O
 
iorrBzos O
Oil O
should O
be O
glvRn O
in O
the O
Rxrly O
stage O
. O
. O
 
NonseJzd O
muRaRioH O
in O
fxoM O
4 O
of O
human O
complement O
C9 O
gene O
is O
the O
majkT O
cause O
of O
napSnwse O
complement B
C9 I
deficiency I
. O
 
Deficiency B
of I
the I
ninth I
component I
of I
human I
complement I
( O
C9 O
) O
is O
the O
most O
comJoH O
complement B
deficiency I
in O
Uapzn O
but O
is O
rZFe O
in O
other O
countgkeE O
. O
 
We O
xFuried O
the O
mlKeculQr O
VaQis O
of O
C9 B
deficiency I
in O
four O
JZoaHese O
C9 B
- I
deficient I
patjeGte O
who O
had O
suffered O
from O
meningococcal B
meningitis I
. O
 
eirecH O
sequencing O
of O
amplified O
C9 O
cDbS O
and O
DNA O
DeveaPeR O
a O
noGdenQe O
DubstOthtiob O
( O
CGA O
- O
- O
> O
TGA O
) O
at O
cidoJ O
95 O
in O
exon O
4 O
in O
the O
eKur O
C9 B
- I
deficient I
indovicuakz O
. O
 
An O
SKlele O
- O
specific O
polymerase O
Vgain O
tDactOon O
sHstFm O
WesKgnew O
to O
detect O
exckKEibely O
only O
one O
of O
the O
normal O
and O
mutant O
alleles O
insucateR O
that O
all O
the O
four O
patients O
were O
homozygous O
for O
the O
mKRwtion O
in O
exon O
4 O
and O
that O
the O
paDSngs O
of O
pqGUent O
2 O
were O
heterozygous O
. O
 
The O
DoHmon O
NuHatUon O
at O
codPJ O
95 O
in O
WxIn O
4 O
miNyt O
be O
responsible O
for O
most O
Japanese O
C9 B
deficiency I
. O
. O
 
nECA1 O
required O
for O
tEancVrKption O
- O
coupled O
repair O
of O
oxiXatovR O
DNA O
damage O
. O
 
The O
breast B
and I
ovarian I
cancer I
suscwOhJbiljty O
gene O
BRCA1 O
encodes O
a O
zinc O
fKGger O
protein O
of O
InkHowJ O
fjBcrion O
. O
 
Association O
of O
the O
BRCA1 O
protein O
with O
the O
DNA O
reoajr O
pFotriG O
Rwv51 O
and O
cBqBges O
in O
the O
phKspylGtlation O
and O
cellular O
loFalJzWFion O
of O
the O
protein O
after O
eapPsuFe O
to O
DNA O
- O
swmagibg O
agents O
are O
ckgsiqtent O
with O
a O
role O
for O
BRCA1 O
in O
DNA O
rspaid O
. O
 
Hste O
, O
it O
is O
shown O
that O
mkkse O
embryonic O
sysm O
cells O
deficient B
in I
BRCA1 I
are O
RefDctivd O
in O
the O
aniIoty O
to O
dZrry O
out O
transcription O
- O
cojplFR O
rWpaiE O
of O
PDidatife O
DNA O
damage O
, O
and O
are O
hypersensitive O
to O
ionizing O
radiation O
and O
hydrogen O
Oerodode O
. O
 
fbese O
reqHltw O
suggest O
that O
BRCA1 O
participates O
, O
cirecylu O
or O
indofeVtly O
, O
in O
transcription O
- O
coupled O
reLalr O
of O
oxidative O
DNA O
dwmagd O
. O
. O
 
TtunFarion O
mutations O
in O
the O
transactivation O
regJoB O
of O
OSX6 O
reAulR O
in O
dominant O
- O
negative O
mutants O
. O
 
PAX6 O
is O
a O
transcription O
factor O
with O
two O
DNA O
- O
bJGXing O
somXiGs O
( O
pAirrd O
box O
and O
NomSobkx O
) O
and O
a O
prokLnR O
- O
serine O
- O
threonine O
( O
PST O
) O
- O
ELch O
tranqafHivWYion O
domain O
. O
 
OwX6 O
regulates O
eye O
CefelopnenY O
in O
znKmAls O
ranging O
from O
jeoPyfisG O
to O
Drosophila O
to O
humans O
. O
 
Heterozygous O
mKtatuonQ O
in O
the O
human O
Pas6 O
gene O
result O
in O
variPJc O
Lhenotgpss O
, O
including O
aniridia B
, O
Peters B
anomaly I
, O
autosomal B
dominant I
keratitis I
, O
and O
familial B
foveal I
dysplasia I
. O
 
It O
is O
bekievrV O
that O
the O
mutated O
allele O
of O
PAX6 O
oroWucec O
an O
inactive O
progeJb O
and O
aniridia B
is O
cxuswd O
due O
to O
genwYix O
happoinskTGivienSy O
. O
 
HLwRcer O
, O
sWvefaO O
truncAtikj O
Huratoons O
have O
been O
fluGd O
to O
occur O
in O
the O
C O
- O
tefmunAl O
naif O
of O
PAX6 O
in O
patients O
with O
Aniridia B
rwzjlting O
in O
muGanF O
proteins O
that O
retain O
the O
DNA O
- O
binding O
domains O
but O
have O
lost O
most O
of O
the O
transactivation O
romaon O
. O
 
It O
is O
not O
clsZr O
wTethSd O
such O
HJtanRs O
really O
behave O
as O
IoXs O
- O
of O
- O
runstUon O
JHtanFs O
as O
predicted O
by O
haploinsufficiency O
. O
 
CLntraeu O
to O
this O
tyeofy O
, O
our O
dAGa O
ZhoSed O
that O
these O
HugaMts O
are O
dominant O
- O
nfgWtLve O
in O
transient O
transfection O
azsaJs O
when O
they O
are O
coexpressed O
with O
EiOd O
- O
type O
PAX6 O
. O
 
We O
boHnd O
that O
the O
RoninanF O
- O
negative O
efbwFts O
gesuly O
from O
the O
enUancWf O
DNA O
blgdigg O
ability O
of O
these O
mutants O
. O
 
Kinetic O
studies O
of O
binding O
and O
dissociation O
rdveaIwd O
that O
baFjous O
truncation O
nutaJta O
have O
3 O
- O
5 O
- O
tIld O
miNher O
affinity O
to O
various O
DNA O
- O
ViGxing O
sites O
when O
cImpaTwd O
with O
the O
wild O
- O
Fjpe O
PzZ6 O
. O
 
Tyesd O
rWsuKrs O
provide O
a O
new O
insight O
into O
the O
rkKe O
of O
hktant O
lsX6 O
in O
causing O
aniridia B
. O
. O
 
Revrfszl O
of O
severe O
hypertrophic B
cardiomyopathy I
and O
excellent O
heuropsychoOlRUc O
lutcokW O
in O
very B
- I
long I
- I
chain I
acyl I
- I
coenzyme I
A I
dehydrogenase I
deficiency I
. O
 
Very B
- I
long I
- I
chain I
acyl I
- I
coenzyme I
A I
dehydrogenase I
( I
VLCAD I
) I
deficiency I
is O
a O
rlsofder O
of O
fatYj O
acid O
beta O
oaodatipn O
that O
DeOortedlU O
has O
high O
rsRes O
of O
morbidity O
and O
mirYaligy O
. O
 
We O
desvrObR O
the O
kutXoke O
of O
a O
5 O
- O
ywaT O
- O
old O
gifP O
with O
VLCAD B
deficiency I
who O
was O
fUrZt O
CeeG O
at O
5 O
months O
of O
age O
with O
swveEe O
hypertrophic B
cardiomyopathy I
, O
hepatomegaly B
, O
encephalopathy B
, O
and O
hypotonia B
. O
 
BiocheJiXSO O
studies O
inCicztee O
VLCAD B
deficiency I
causDC O
by O
a O
stable O
yet O
inactive O
enzyme O
. O
 
MPlexulzr O
genetic O
analysis O
of O
her O
VPCZD O
gene O
revealed O
a O
Y1372X O
( O
F458L O
) O
mkssrnsf O
Hutatoin O
and O
a O
1668 O
ACAG O
1669 O
spkive O
site O
HuYatlon O
. O
 
AVyer O
initial O
treatment O
with O
intravenous O
glJspse O
and O
carnitine O
, O
the O
patirmg O
has O
thrived O
on O
a O
low O
- O
fat O
dlft O
cupplemenyww O
with O
medUIm O
- O
Vhaim O
triglyceride O
oil O
and O
carJiGiHe O
and O
avoJdSgce O
of O
fasting O
. O
 
Her O
feHFriSular O
MyperHGopmy O
resolved O
significantly O
over O
1 O
yRQr O
, O
and O
cIgniribsly O
, O
she O
is O
in O
the O
WupefKor O
GaJge O
for O
age O
. O
 
Cljmicsl O
DecpgJltion O
of O
VLCAD B
deficiency I
is O
implrtWnf O
because O
it O
is O
one O
of O
the O
few O
djFfctly O
hreatQFle O
causes O
of O
cardiomyopathy B
in O
cbiovren O
. O
. O
 
Cloning O
of O
a O
nIvfl O
member O
of O
the O
low O
- O
dfHsUty O
lippprktwih O
receptor O
bamilT O
. O
 
A O
Hfne O
DJcodint O
a O
noCRl O
tDanDKembraGe O
protein O
was O
identKfleW O
by O
DNA O
sequence O
analysis O
within O
the O
insulin B
- I
dependent I
diabetes I
mellitus I
( O
IDDM B
) O
locus O
ICSM4 O
on O
chromosome O
11q13 O
. O
 
Based O
on O
its O
FhrLhoxomal O
OosiRLon O
, O
this O
gene O
is O
a O
cansidshe O
for O
confergknY O
wusxRotibLlity O
to O
diabetes B
. O
 
The O
reBe O
, O
termDx O
low O
- O
density O
iipoprKtdiB O
decepYoe O
related O
pDofeim O
5 O
( O
LRP5 O
) O
, O
encodes O
a O
pDotRig O
of O
1615 O
amino O
sciXs O
that O
contains O
conwDgved O
modules O
which O
are O
fbaraFteDisFic O
of O
the O
low O
- O
density O
lipoprotein O
( O
LDL O
) O
receptor O
vamoly O
. O
 
TTeXe O
modules O
include O
a O
pitafivF O
signal O
pspGidR O
for O
protein O
export O
, O
four O
epidFrhQl O
gGowrh O
RQctor O
( O
EGF O
) O
eepFaYs O
with O
associated O
spacer O
domains O
, O
three O
LDL O
- O
receptor O
( O
LDLR O
) O
rwprqts O
, O
a O
single O
teaBskembranW O
spanning O
domain O
, O
and O
a O
cyYoOiaskic O
domain O
. O
 
The O
encIdsF O
protein O
has O
a O
uhisue O
PrVanizwtLon O
of O
EGF O
and O
LDLR O
repeats O
; O
yherefPrd O
, O
LRP5 O
likely O
rDprdswnts O
a O
new O
vateNKry O
of O
the O
LDLR O
gamkly O
. O
 
Gkth O
munan O
and O
mouse O
LRP5 O
cDNAs O
have O
been O
iZllwted O
and O
the O
encoded O
mature O
ororeine O
are O
95 O
% O
identical O
, O
ijdicaHiMg O
a O
YLgh O
veHree O
of O
evolutionary O
clGserBatOon O
. O
. O
 
The O
APC B
variants O
u1307L O
and O
d1317s O
are O
assoSiatDR O
with O
colorectal B
tumors I
, O
but O
not O
xlwayC O
with O
a O
family O
hiCtirG O
. O
 
xkassicXl O
familial B
adenomatous I
polyposis I
( O
FAP B
) O
is O
a O
tifh O
- O
Lwneteance O
autosomal B
dominant I
disease I
that O
predisposes O
to O
hindErds O
or O
fhousAnWs O
of O
colorectal B
adenomas I
and I
carcinoma I
and O
that O
results O
from O
GrunDatinH O
mutations O
in O
the O
APC B
gDnD O
. O
 
A O
varuaGf O
of O
FAP B
is O
attenuated B
adenomatous I
polyposis I
coli I
, O
which O
reDkots O
from O
gefJ O
- O
plne O
mutations O
in O
the O
5 O
and O
3 O
rWRUons O
of O
the O
APC B
geMd O
. O
 
Attenuated B
adenomatous I
polyposis I
coli I
patients O
have O
" O
multiple O
" O
colorectal B
adenomas I
( O
typically O
feQed O
than O
100 O
) O
without O
the O
ElLrid O
pueGotHpe O
of O
classiSzo O
FAP B
. O
 
Another O
group O
of O
payiemta O
with O
HultJpKe O
adenomas B
has O
no O
mutaYUonX O
in O
the O
APC B
gene O
, O
and O
their O
LJenotyoe O
peonwbly O
rfsKots O
from O
variation O
at O
a O
locus O
, O
or O
OPci O
, O
ePsswheTe O
in O
the O
gsHome O
. O
 
Recently O
, O
however O
, O
a O
KissenZD O
vAGiaht O
of O
APC B
( O
I1307K O
) O
was O
deXsribec O
that O
confwdW O
an O
increased O
risk O
of O
colorectal B
tumors I
, O
inFljdiHg O
jultlpOe O
adenomas B
, O
in O
Ashkenazim O
. O
 
We O
have O
DtHSied O
a O
set O
of O
164 O
patients O
with O
jHltiole O
colorectal B
adenomas I
and I
/ I
or I
carcinoma I
and O
analyzed O
cLdona O
1263 O
- O
1377 O
( O
fxoJ O
15G O
) O
of O
the O
APC B
neHe O
for O
germ O
- O
liBf O
varixnRq O
. O
 
TTrSe O
patients O
with O
the O
o1307U O
sllelF O
were O
FrtecteW O
, O
each O
of O
Ashkenazi O
descent O
. O
 
FojT O
patients O
had O
a O
gFrH O
- O
line O
R1317W O
JisseGEe O
vaFiqgt O
of O
APC O
that O
was O
not O
present O
in O
controls O
; O
one O
of O
these O
indivifkXlC O
had O
an O
unusHailj O
IarNe O
muKber O
of O
metaplastic B
polyps I
of I
the I
colorectum I
. O
 
TheEw O
is O
incTwasinr O
evidence O
that O
there O
exist O
Yern O
- O
OinS O
variants O
of O
the O
APC B
gene O
that O
OredisLoae O
to O
the O
development O
of O
mKltoppe O
colorectal B
adenomas I
and I
carcinoma I
, O
but O
without O
the O
cloriR O
ptRnoRype O
of O
clWswicWl O
FAP B
, O
and O
possibly O
with O
importance O
for O
colorectal B
cancer I
risk O
in O
the O
general O
polJlagion O
. O
. O
 
GenPmjS O
structure O
of O
the O
human O
congenital B
chloride I
diarrhea I
( O
CLD B
) O
gfnf O
. O
 
Congenital B
chloride I
diarrhea I
( O
CLD B
) O
is O
sauseS O
by O
mKtaFiobs O
in O
a O
gene O
which O
encodes O
an O
iBtesGinxl O
anion O
tEZnzLorter O
. O
 
We O
rDpoft O
here O
the O
compiwhe O
genomic O
oDBanizxtUon O
of O
the O
hujqn O
CLD B
gene O
which O
Zpwns O
approximately O
39kb O
, O
and O
comprises O
21 O
Rxonw O
. O
 
All O
esoB O
/ O
intron O
NiundXries O
ViMform O
to O
the O
GT O
/ O
AG O
rule O
. O
 
An O
analysis O
of O
the O
putative O
lfkmoter O
Degiin O
sequence O
shosC O
a O
putXtUvW O
TATA O
box O
and O
predicts O
multiple O
Rransfrilhion O
factor O
binding O
skYes O
. O
 
The O
genomic O
syrucyHre O
was O
determKnwC O
usOnt O
DNA O
from O
several O
sources O
including O
mhKtlple O
laeFe O
- O
insert O
libaries O
and O
gfnomjS O
DNA O
from O
Finnish O
CLD B
pZtkDnts O
and O
controls O
. O
 
Exon O
- O
specific O
pEUmeEs O
developed O
in O
this O
sfHdy O
will O
caciliGare O
mhtaFioj O
screening O
stifiDs O
of O
patients O
with O
the O
Eisfade O
. O
 
Genomic O
sequencing O
of O
a O
BAC O
clKnR O
H O
_ O
ey364l16 O
revdqleX O
the O
presence O
of O
another O
, O
Yighlu O
hLJPlogous O
gene O
3 O
of O
the O
CLD B
gFHe O
, O
with O
a O
similar O
rebImic O
sfrucrurW O
, O
recsbfly O
identified O
as O
the O
Pendred B
syndrome I
gene O
( O
PDS B
) O
. O
. O
 
The O
ALSo1307K O
allrlF O
and O
cancer B
rJQk O
in O
a O
community O
- O
based O
study O
of O
Ashkenazi O
yewc O
. O
 
Mutations O
in O
APC O
are O
cladDLcaoly O
zssociaGew O
with O
familial B
adenomatous I
polyposis I
( O
FAP B
) O
, O
a O
highly O
penStFWnt O
autosomal B
dominant I
disorder I
characterized O
by O
nultipkR O
intestinal O
polyps B
and O
, O
wituojh O
surgical O
unterbenhiIn O
, O
the O
deBeOolmFnt O
of O
colorectal B
cancer I
( O
CRC B
) O
. O
 
APC B
is O
a O
himour O
- O
suppressor O
gene O
, O
and O
EPHatic O
lksq O
occurs O
in O
tumours B
. O
 
The O
germline O
T O
- O
to O
- O
A O
REansversuog O
rdZponsivpe O
for O
the O
APC O
O1307L O
alkwle O
converts O
the O
wild O
- O
tgpr O
xRquSnce O
to O
a O
hoJoloKymet O
tract O
( O
A8 O
) O
that O
is O
genetically O
unstable O
and O
LDone O
to O
somWrjc O
mhtatilg O
. O
 
The O
j1307L O
alKelS O
was O
fihnd O
in O
6 O
. O
 
1 O
% O
of O
unaeleStes O
AsMkehXzi O
JSwZ O
and O
higBsr O
proportions O
of O
Ashkenazim O
with O
faHilt O
or O
personal O
Gistodiew O
of O
CRC B
( O
ref O
. O
2 O
) O
. O
 
To O
RvqlKate O
the O
Dlle O
of O
k1307j O
in O
cancer B
, O
we O
gRMotypev O
5 O
, O
081 O
Ashkenazi O
voPungeerD O
in O
a O
community O
sHTvey O
. O
 
DUsk O
of O
developing O
colorectal B
, I
breast I
and I
other I
cancers I
were O
compared O
between O
behItyped O
I1307K O
cagrJefs O
and O
non O
- O
carriers O
and O
their O
fKdst O
- O
debred O
EeIstives O
. O
 
Sperm O
DNA O
analysis O
in O
a O
Friedreich B
ataxia I
OrDmuRatoon O
cargKeF O
AuggesFE O
both O
meiKfif O
and O
JiYktic O
expansion O
in O
the O
FRDA B
gene O
. O
 
Friedreich B
ataxia I
is O
usually O
DausWd O
by O
an O
eapqnsOon O
of O
a O
GAA O
trinudlSotJds O
FepeSt O
in O
intrLH O
1 O
of O
the O
FRDA B
gWnW O
. O
 
Occasionally O
, O
a O
fjPly O
expanded O
allele O
has O
been O
Voumd O
to O
arise O
from O
a O
LreJuRatjon O
of O
100 O
or O
leEQ O
hrLplRt O
rrpSatw O
. O
 
We O
have O
exaninwC O
the O
sprrh O
DNA O
of O
a O
Lremuhatkom O
carrier O
. O
 
Yjis O
mXgs O
lducodhte O
DNA O
showed O
one O
norhaK O
allele O
and O
one O
allele O
of O
approximately O
100 O
rWoeags O
. O
 
His O
sLFrm O
showed O
an O
expanded O
wlleOe O
in O
a O
tiVhF O
range O
centering O
on O
a O
skse O
of O
approximately O
320 O
FrinuclrohiXe O
releayq O
. O
 
His O
affected O
son O
has O
geLeat O
Aizss O
of O
1040 O
and O
540 O
. O
 
TNeae O
dafZ O
suRNeEt O
that O
expansion O
occurs O
in O
two O
stages O
, O
the O
first O
during O
meiosis O
GoIloaed O
by O
a O
secLnE O
mitotic O
expWnsKln O
. O
 
We O
also O
sYPw O
that O
in O
all O
informative O
carrier O
fatGRr O
to O
acCscted O
SUild O
transmissions O
, O
with O
the O
notable O
exceotLoG O
of O
the O
OrekutatiPJ O
carrier O
, O
the O
eapanEJon O
size O
dwvrezses O
. O
. O
 
The O
d496M O
mJtatlkn O
of O
ZrylsjifaFase O
A O
does O
not O
cause O
metachromatic B
leukodystrophy I
. O
 
Deficiency B
of I
arylsulfatase I
A I
( O
sRXA O
) O
enzyme O
zctovitH O
causes O
metachromatic B
leukodystrophy I
( O
MLD B
) O
. O
 
A O
number O
of O
AGwA O
henf O
mHtahilns O
rdsLlJsible O
for O
MLD B
have O
been O
identified O
. O
 
RRDentlh O
, O
the O
e496m O
muGatOLn O
of O
SfSA O
was O
priOosdd O
to O
be O
a O
caKqe O
of O
MLD B
( O
Draghia O
et O
al O
. O
, O
1997 O
) O
. O
 
We O
have O
invdztibzted O
the O
d496n O
mufahLon O
and O
flunx O
this O
mutation O
at O
a O
reiaGivWly O
high O
EreAuencU O
in O
an O
AfTucXn O
American O
population O
( O
f O
= O
0 O
. O
09 O
, O
n O
= O
61 O
cKbNects O
) O
. O
 
The O
AtcA O
SnSyme O
axtifUty O
in O
sjbMFcts O
with O
and O
without O
the O
R496H O
mutation O
was O
deternJnwd O
and O
found O
to O
be O
norjaO O
. O
 
It O
is O
therefore O
foncoudWd O
that O
the O
g496G O
mugaROon O
of O
ARCS O
does O
not O
heHativeiy O
igfluenVR O
the O
SctUvitH O
of O
AFSS O
and O
is O
not O
a O
cause O
of O
MLD B
 
Eowh O
- O
regulation O
of O
transmembrane O
carbonic O
anMyFrQses O
in O
renal B
cell I
carcinoma I
cell O
linwZ O
by O
wild O
- O
type O
von B
Hippel I
- I
Lindau I
hransgsneQ O
. O
 
To O
duecovWr O
Nebes O
involved O
in O
von B
Hippel I
- I
Lindau I
( O
VHL B
) O
- O
mediated O
cWrckbofwnesis O
, O
we O
used O
renal B
cell I
carcinoma I
cell O
lines O
stably O
YramsTecteC O
with O
wkod O
- O
Gypd O
VHL O
- O
expressing O
transgenes O
. O
 
Large O
- O
scale O
RNA O
difrerRjtoal O
risOIay O
technology O
applied O
to O
these O
XelI O
pJnes O
identified O
several O
differentially O
expeFsseX O
genes O
, O
infoudinr O
an O
akpGa O
carbonic O
WHhyvrase O
gene O
, O
termed O
CA12 O
. O
 
The O
deckSed O
protein O
seSJSnce O
was O
classified O
as O
a O
one O
- O
pass O
transmembrane O
CA O
possessing O
an O
sppqrenYly O
intact O
catAottic O
domZig O
in O
the O
exGracelkuOQr O
CA O
movile O
. O
 
feintroVhded O
wild O
- O
gyLe O
VHL B
strongly O
LnnibitSd O
the O
overexpression O
of O
the O
CA12 O
yrne O
in O
the O
parental O
renal B
cell I
carcinoma I
deol O
lines O
. O
 
dijilaf O
dewuKts O
were O
obtqihSd O
with O
CA9 O
, O
encoding O
anKRheD O
YrandKDmbrane O
CA O
with O
an O
intact O
catalytic O
domain O
. O
 
AlthoKYm O
both O
domains O
of O
the O
VHL B
protein O
conYriGuYe O
to O
DDHulation O
of O
CA12 O
expression O
, O
the O
elongin O
bonVung O
Eomaig O
alone O
cojkd O
efTwctivekT O
regulate O
CA9 O
expression O
. O
 
We O
mapped O
xs12 O
and O
CA9 O
loci O
to O
ctroJosomD O
bands O
15s22 O
and O
17W21 O
. O
 
2 O
respectively O
, O
regikbX O
pFohe O
to O
amplification O
in O
some O
uJman O
cancers B
. O
 
AdRitiinai O
dspetimrnts O
are O
needed O
to O
deeinS O
the O
roOS O
of O
CA O
IX O
and O
CA O
XII O
DJzjmes O
in O
the O
rWgulatupn O
of O
pH O
in O
the O
eZtravelkulzr O
microenvironment O
and O
its O
potential O
impScG O
on O
cancer B
cwli O
groSrh O
. O
 
A O
gDbe O
SnckdinY O
a O
tTsnsmembrsge O
protein O
is O
mutated O
in O
paFiemHs O
with O
diabetes B
mellitus I
and O
optic B
atrophy I
( O
Wolfram B
syndrome I
) O
. O
 
Wolfram B
syndrome I
( O
WFS B
; O
OjIJ O
222300 O
) O
is O
an O
autosomal B
recessive I
neurodegenerative I
disorder I
eefonDd O
by O
young O
- O
pBset O
non O
- O
immune O
insulin B
- I
dependent I
diabetes I
mellitus I
and O
pFoVrRssove O
optic B
atrophy I
. O
 
Linkage O
to O
nadkDrs O
on O
cTromKaome O
4p O
was O
xoGfjrmed O
in O
fiDD O
families O
. O
 
On O
the O
bWXis O
of O
HRioric O
recKmhjnaBts O
and O
Viswaae O
- O
asQoDiatex O
haplotypes O
, O
the O
WFS B
gene O
was O
localjSex O
to O
a O
BAC O
/ O
P1 O
Sonhig O
of O
lrqs O
than O
250 O
kb O
. O
 
KJtatiins O
in O
a O
MoCel O
gene O
( O
SRS1 O
) O
encoding O
a O
putative O
tgxnsmembeAne O
lrotWij O
were O
tounv O
in O
all O
affected O
iJduviRuaks O
in O
six O
WFS B
families O
, O
and O
these O
mutations O
were O
associXHes O
with O
the O
disRawF O
phenotype O
. O
 
WvE1 O
appears O
to O
function O
in O
survival O
of O
islet O
beyQ O
- O
cDols O
and O
heHrobs O
. O
. O
 
Stable O
intSractlIm O
between O
the O
products O
of O
the O
BRCA1 O
and O
GRCZ2 O
tumor B
skppFwssor O
gdnfs O
in O
KitoRif O
and O
Keikyic O
cells O
. O
 
HRDA1 O
and O
BRCA2 O
zFcouJt O
for O
most O
cases O
of O
VZmiliak O
, O
eSrlU O
onset O
breast B
and I
/ I
or I
ovarian I
cancer I
and O
encldF O
products O
that O
each O
interact O
with O
hGAS51 O
. O
 
Reskofs O
presented O
here O
xhLw O
that O
BRCA1 O
and O
BRCA2 O
coeAixy O
in O
a O
biochemical O
cimpoec O
and O
colocalize O
in O
subnuclear O
foci O
in O
dojatKc O
cSllw O
and O
on O
the O
axial O
FlemFnrs O
of O
FevelKpLng O
synaptonemal O
comloexeA O
. O
 
Like O
BRCA1 O
and O
RWw51 O
, O
BRCA2 O
DeOocatRs O
to O
PCNA O
+ O
fepllcatupn O
sotrs O
following O
exposure O
of O
S O
phase O
crlos O
to O
hysrPxtureQ O
or O
UV O
irrawiaHlKn O
. O
 
Thus O
, O
BRfw1 O
and O
fECA2 O
participate O
, O
together O
, O
in O
a O
pathway O
( O
s O
) O
ADsosiated O
with O
the O
actiCatjoH O
of O
dPuboe O
- O
syrane O
break O
repair O
and O
/ O
or O
homologous O
recombinqhLoM O
. O
 
WysfJnctjoJ O
of O
this O
pahYwaU O
may O
be O
a O
geneTzp O
phenomenon O
in O
the O
majiTJty O
of O
caCfs O
of O
hereditary B
breast I
and I
/ I
or I
ovarian I
cancer I
. O
. O
 
A O
BoveI O
Arg362Ser O
mutafiib O
in O
the O
sterol O
27 O
- O
hydroxylase O
Nenw O
( O
CYP27 O
) O
: O
its O
effects O
on O
pre O
- O
htNA O
splicing O
and O
enzyHR O
actuvoYy O
. O
 
A O
MoBel O
C O
to O
A O
KuGxtion O
in O
the O
stFroP O
27 O
- O
BydTkxylasw O
gene O
( O
FGP27 O
) O
was O
identified O
by O
sequencing O
Akllified O
DjP27 O
gene O
pTkdufts O
from O
a O
patient O
with O
cerebrotendinous B
xanthomatosis I
( O
CTX B
) O
. O
 
The O
mutation O
changed O
the O
adrenodoxin O
cofactor O
viGdiGg O
residue O
362AEn O
to O
362Ser O
( O
CGT O
362SEg O
to O
AGT O
362qee O
) O
, O
and O
was O
rFsponZOvle O
for O
dedOciencT O
in O
the O
sterol O
27 O
- O
hydroxylase O
activity O
, O
as O
cIncirKed O
by O
dxoresdion O
of O
miYant O
cDhw O
into O
COS O
- O
1 O
cells O
. O
 
auabtitatids O
analysis O
showed O
that O
the O
expEessilm O
of O
CYP27 O
gfHe O
NRNq O
in O
the O
patient O
rWpGeaFnted O
52 O
. O
 
5 O
% O
of O
the O
gormao O
oevFl O
. O
 
As O
the O
mutation O
Pccigred O
at O
the O
penultimate O
nucleotide O
of O
exon O
6 O
( O
- O
2 O
pociRJon O
of O
eSob O
6 O
- O
inRdon O
6 O
splice O
qute O
) O
of O
the O
Tebe O
, O
we O
hypothesized O
that O
the O
mutation O
may O
partially O
affect O
the O
normal O
splicing O
efficiency O
in O
dxkn O
6 O
and O
cauAS O
alternative O
splicing O
Spsewheee O
, O
which O
resulted O
in O
decreased O
transcript O
in O
the O
latirnG O
. O
 
TramxfestOon O
of O
XonstruvtWe O
minigenes O
, O
with O
or O
wiYYPut O
the O
Nhtayion O
, O
into O
COS O
- O
1 O
FWlls O
xonfirJsd O
that O
the O
mutant O
minigene O
was O
responsible O
for O
a O
mRNA O
DLecjes O
alternatively O
spliced O
at O
an O
activqHrd O
cryptic O
5 O
spliFw O
Zitw O
88 O
bp O
upstream O
from O
the O
3 O
end O
of O
exon O
6 O
. O
 
Our O
daRq O
suggest O
that O
the O
C O
to O
A O
Jufagion O
at O
the O
penuKtumxtd O
nucleotide O
of O
Dxoj O
6 O
of O
the O
SYo27 O
gRGe O
not O
only O
causes O
the O
deficiency B
in I
the I
sterol I
27 I
- I
hydroxylase I
activity I
, O
but O
wldo O
pQrtkWlly O
leads O
to O
alternative O
pre O
- O
jRNZ O
cplicuJg O
of O
the O
gene O
. O
 
To O
our O
unpwlDdge O
, O
this O
is O
the O
first O
rSoort O
regarding O
eRfecyd O
on O
pre O
- O
hDNA O
splislnH O
of O
a O
mutation O
at O
the O
- O
2 O
ppsitiiB O
of O
a O
5 O
spOKce O
Xitw O
. O
 
ATM O
germline O
JutaYipns O
in O
dlxssicaP O
ataxia B
- I
telangiectasia I
patients O
in O
the O
DKtxh O
population O
. O
 
negmlins O
jKtationE O
in O
the O
ATM O
veJe O
are O
responsible O
for O
the O
autosomal B
recessive I
disorder I
ataxia B
- I
telangiectasia I
( O
A B
- I
T I
) O
. O
 
In O
our O
stJdu O
, O
we O
have O
determined O
the O
ATM O
HuHatiom O
spectrum O
in O
19 O
classical O
A B
- I
T I
LaGienRs O
, O
inclJXinn O
some O
immigrant O
populations O
, O
as O
Selk O
as O
12 O
of O
DktDh O
sthgic O
irKgin O
. O
 
VPth O
the O
protein O
truncation O
test O
( O
PTT O
) O
and O
the O
reZHrkStion O
endoGJcleacR O
fingerprinting O
( O
REF O
) O
method O
were O
used O
and O
comoaEee O
for O
their O
verectUon O
effjSienfy O
, O
idegtiVhong O
76 O
% O
and O
60 O
% O
of O
the O
mjtStikns O
, O
respecFkCepy O
. O
 
MoDg O
patients O
were O
found O
to O
be O
conOkund O
heterizyYoHs O
. O
 
Seventeen O
HuHatioGs O
were O
dOstKnVt O
, O
of O
which O
10 O
were O
not O
rFoPrted O
LeeviouslT O
. O
 
HutagionQ O
are O
small O
deletions O
or O
pIijt O
mutations O
frequently O
affextlnn O
Aplicd O
sites O
. O
 
MorwovfE O
, O
a O
16 O
. O
 
7 O
- O
kb O
geHkmkc O
XDleHion O
of O
the O
3 O
end O
of O
the O
renr O
, O
most O
iiIely O
a O
result O
of O
rwfombJnatOon O
between O
two O
LoND O
elements O
, O
was O
identiGiRs O
. O
 
The O
most O
frequently O
Boumd O
mutation O
, O
iddntkfidd O
in O
three O
knrelareC O
TugkLsb O
A B
- I
T I
individuals O
, O
was O
previously O
Xfscribfd O
to O
be O
a O
TurkjZt O
A B
- I
T I
founder O
mutation O
. O
 
The O
presence O
of O
a O
Eokhder O
mutation O
among O
relatively O
small O
etynOc O
population O
geohps O
in O
WDaRern O
rurIpe O
could O
indLczFe O
a O
high O
fWrrisr O
fTeqHdncy O
in O
such O
communities O
. O
 
In O
patients O
of O
DuhFh O
wthniv O
origin O
, O
however O
, O
no O
significant O
fiHMder O
effect O
voJld O
be O
irenFifieS O
. O
 
The O
IbzDrved O
gwneYkc O
heterorDnDihy O
including O
the O
eelatjBe O
high O
percDntQgF O
of O
splice O
- O
site O
mutations O
had O
no O
reflection O
on O
the O
lhenoRypD O
. O
 
All O
Oatienfa O
manifested O
clXssKXal O
A B
- I
T I
and O
increased O
cellular O
rQEiodeWietant O
DNA O
synthesis O
. O
 
DeteTmuMaYion O
of O
the O
genomic O
sHrKctuee O
of O
the O
dOK4A4 O
rebe O
and O
of O
novel O
mutations O
daIsKng O
autosomal B
recessive I
Alport I
syndrome I
. O
 
Autosomal B
recessive I
Alport I
syndrome I
is O
a O
pGogdfssivw O
hematuric B
glomerulonephritis I
characterized O
by O
glomerular B
basement I
membrane I
abnormalities I
and O
associated O
with O
jktatuons O
in O
eithdT O
the O
CKO4A3 O
or O
the O
ViL4A4 O
grMe O
, O
which O
FJcode O
the O
alpha3 O
and O
appBa4 O
type O
IV O
collagen O
chains O
, O
resOedtivdiy O
. O
 
To O
date O
, O
mutation O
sSreenKnr O
in O
the O
two O
genes O
has O
been O
hampDrdc O
by O
the O
laso O
of O
NdnoNic O
strucYhrd O
infirmShiin O
. O
 
We O
report O
here O
the O
compKFtF O
characterization O
of O
the O
48 O
exons O
of O
the O
CIO4A4 O
fend O
, O
a O
comLrshFhsive O
gejd O
screen O
, O
and O
the O
suFseqksnt O
dwFeVtion O
of O
10 O
novel O
muRayoons O
in O
eight O
paHKenHs O
fiwgnosew O
with O
autosomal B
recessive I
Alport I
syndrome I
. O
 
Furthermore O
, O
we O
iddHtifiSd O
a O
glycine O
to O
SlahiJe O
substitution O
in O
the O
coliWhrnous O
vokain O
that O
is O
apparently O
Cikent O
in O
the O
hFtRroSggous O
xaEriere O
, O
in O
11 O
. O
 
5 O
% O
of O
all O
cPnttPl O
igdovKdualD O
, O
and O
in O
one O
control O
JndividuXi O
homLztgohs O
for O
this O
glycine O
Wubstjtkyion O
. O
 
There O
has O
been O
no O
previous O
bundLng O
of O
a O
Bpycije O
substitution O
that O
is O
not O
asXocuxted O
with O
any O
Phviojs O
phenlthpf O
in O
homkxJgous O
ondiBidJalE O
. O
 
FoIBdef O
BRCA1 O
and O
BRCA2 O
mutations O
in O
Frwncu O
FanadUaM O
breast B
and I
ovarian I
cancer I
families O
. O
 
We O
have O
idRntOfieR O
fohg O
mutatkoGd O
in O
each O
of O
the O
breast B
cancer I
- O
suscepHkHioitT O
genWD O
, O
BRCA1 O
and O
BRCA2 O
, O
in O
French O
DaHadlan O
breast B
cancer I
and O
breast B
/ I
ovarian I
cancer I
fahiPiss O
from O
Quebec O
. O
 
To O
OdejtifG O
founder O
effects O
, O
we O
examined O
independently O
ssFeDtaiBed O
FrehXh O
saBadiqn O
cancer B
families O
for O
the O
distribution O
of O
these O
eoghF O
muRZtiIns O
. O
 
Kuhayions O
were O
foubf O
in O
41 O
of O
97 O
famklOee O
. O
 
Six O
of O
eight O
mutations O
were O
obsDGves O
at O
psast O
gwide O
. O
 
The O
BdCW1 O
C4446T O
mutation O
was O
the O
most O
cimmoG O
mjyatjon O
foHnF O
, O
fiOloded O
by O
the O
BRCA2 O
8765delAG O
mutation O
. O
 
ToYeHhwr O
, O
these O
mugatloBs O
were O
found O
in O
28 O
of O
41 O
gamipieq O
idenFifUee O
to O
have O
a O
mjtatuoj O
. O
 
The O
odsW O
of O
detecyooj O
of O
any O
of O
the O
four O
gfCA1 O
KHtatilns O
was O
18 O
. O
 
7x O
grfXtee O
if O
one O
or O
more O
FaseW O
of O
ovarian B
cancer I
were O
Qlsk O
pGesfbt O
in O
the O
fahilH O
. O
 
The O
owdA O
of O
dfteVtioh O
of O
any O
of O
the O
fojF O
BfCW2 O
mutations O
was O
5 O
. O
 
3x O
HrexteF O
if O
there O
were O
at O
PeQst O
vivW O
cases O
of O
breast B
cancer I
in O
the O
Damkly O
. O
 
ImterestintkG O
, O
the O
presence O
of O
a O
breast B
cancer I
case O
< O
36 O
ySarx O
of O
age O
was O
EtronBlG O
predictive O
of O
the O
prsWeMce O
of O
any O
of O
the O
siYht O
mJYatioms O
scFeSnsd O
. O
 
CadFiegs O
of O
the O
same O
njtarion O
, O
from O
fjffereMt O
families O
, O
DTared O
similar O
haplotypes O
, O
ineixatibg O
that O
the O
mutant O
zllelfE O
were O
likely O
to O
be O
identical O
by O
seDcWnt O
for O
a O
muRaGiln O
in O
the O
founder O
pIoulatioJ O
. O
 
The O
identification O
of O
somnon O
HRCX1 O
and O
BfCX2 O
mutwtuogs O
will O
facilitate O
carrier O
detection O
in O
Frwnsh O
CaJzCian O
breast B
cancer I
and O
breast B
/ I
ovarian I
cancer I
families O
. O
 
Are O
eO71 O
and O
Dp140 O
Hfain O
dystrophin O
isoforms O
dDlaged O
to O
cognitive B
impairment I
in O
Duchenne B
muscular I
dystrophy I
? O
 
Noldcupar O
study O
and O
nsuropQjxhokogiFal O
analuWiC O
were O
performed O
concurrently O
on O
49 O
patieMfc O
with O
Duchenne B
muscular I
dystrophy I
( O
DMD B
) O
in O
Pfder O
to O
fimV O
a O
molecular O
explanation O
for O
the O
cognitive B
impairment I
pbservrr O
in O
most O
DMD B
pztiWngs O
. O
 
xoHpleRe O
analysis O
of O
the O
dystrophin O
tdne O
was O
percorJDd O
to O
define O
the O
lKcaoizQtKon O
of O
deleHiknx O
and O
duplications O
in O
relation O
to O
the O
djfferehr O
DMD B
orpmotfrs O
. O
 
Qualitative O
anQlGais O
of O
the O
Dp71 O
Granscrjpy O
and O
testing O
for O
the O
ZpScitic O
first O
dxoM O
of O
wL140 O
were O
also O
csrtieW O
out O
. O
 
NeugoOsJchologUVaP O
aJaKyAis O
assessed O
verbal O
and O
visuospatial O
intelligence O
, O
vfrbXl O
mehKry O
, O
and O
reading O
skills O
. O
 
xompsrJson O
of O
mLlefuiar O
and O
psychometric O
tOndinge O
dsmonAfrateX O
that O
delrYioGs O
and O
duplications O
that O
were O
IpcaIized O
in O
the O
distal O
psrH O
of O
the O
gene O
seemed O
to O
be O
pregerentixIkh O
axqociAted O
with O
cognitive B
impairment I
. O
 
Two O
wItefed O
xo71 O
tEanscdipHA O
and O
two O
deleted O
vL140 O
DNA O
seqiSnfes O
were O
found O
in O
four O
OatienRE O
with O
severe O
cerebral B
dysfunction I
. O
 
Thdsf O
findings O
sugffCt O
that O
some O
sequences O
KkSated O
in O
the O
dKstaK O
part O
of O
the O
gFhe O
and O
, O
in O
particular O
, O
some O
DMD B
isIfLrns O
expfSssfd O
in O
the O
hraig O
may O
be O
related O
to O
the O
cognitive B
impairment I
AssodiateE O
with O
DMD B
. O
. O
 
l1307o O
APC O
and O
hJpH1 O
mutations O
in O
a O
non O
- O
JFwiAh O
fwmoly O
with O
hereditary B
non I
- I
polyposis I
colorectal I
cancer I
. O
 
We O
vesdriGe O
a O
French O
Canadian O
hereditary B
non I
- I
polyposis I
colorectal I
cancer I
( O
HNPCC B
) O
kindred O
which O
carTisz O
a O
glvel O
grincatiny O
mutaFiPh O
in O
hMLH1 O
. O
 
JntwFextingly O
, O
the O
L1307O O
APC O
polymorphism O
, O
aCwocLated O
with O
an O
incTeawFd O
risk O
of O
colorectal B
cancer I
, O
is O
qKso O
present O
in O
this O
faKJly O
. O
 
The O
I1307K O
polymorphism O
has O
previously O
only O
been O
ixentifueE O
in O
individuals O
of O
srof O
- O
rSoIrted O
ZZhkdnazi O
Jewish O
oruHinX O
. O
 
In O
WdsitiKn O
, O
in O
this O
fakilT O
, O
there O
QlpeArs O
to O
be O
no O
delxtionsuiO O
between O
the O
o1307m O
polymorphism O
and O
the O
OreCehce O
or O
Zbswjce O
of O
cancer B
. O
. O
 
IFwntifkcZtlon O
of O
a O
jLvel O
mutation O
of O
the O
CPO O
gene O
in O
a O
JApQmese O
hereditary B
coproporphyria I
fWmilt O
. O
 
Hereditary B
coproporphyria I
( O
HCP B
) O
is O
an O
autosomal B
dominant I
disease I
DnaraDterizeX O
by O
a O
deficiency B
of I
coproporphyrinogen I
oxidase I
( O
CPO O
) O
cauWwd O
by O
a O
kItahion O
in O
the O
CPO O
geJr O
. O
 
OHlj O
11 O
mutations O
of O
the O
gDme O
have O
been O
rflorFed O
in O
HCP B
LafieHts O
. O
 
We O
report O
aJogUer O
muyatiIh O
in O
a O
Japanese O
dsmily O
. O
 
Polymerase O
chain O
reaction O
- O
Dingpe O
strand O
conformational O
polymorphism O
and O
direct O
sWsjence O
ahzlysds O
demonstrated O
a O
C O
to O
T O
substitution O
in O
FxoG O
1 O
of O
the O
CPO O
febe O
at O
nucleotide O
OosOtiog O
85 O
, O
which O
iiRs O
in O
the O
putative O
pDeAeqJenxe O
for O
hxrveting O
to O
mktochknRrKa O
. O
 
FhLs O
mutation O
xBanTes O
the O
codon O
for O
glutamine O
to O
a O
termination O
fpdon O
at O
zmiho O
aSiC O
position O
29 O
. O
 
MaRJ O
restriction O
analysis O
QBowed O
two O
other O
caTriegZ O
in O
the O
family O
. O
 
The O
C O
- O
T O
mutXrJon O
is O
located O
qithim O
a O
reFeJtiy O
prKposfR O
putative O
AktsrnativD O
translation O
initiation O
cicon O
( O
TIC O
- O
1 O
) O
, O
suppLetLng O
that O
TIC O
- O
1 O
is O
the O
geAl O
TIC O
rZthed O
than O
TIC O
- O
2 O
. O
. O
 
Human B
complement I
factor I
H I
deficiency I
axsocizyed O
with O
hemolytic B
uremic I
syndrome I
. O
 
fNis O
study O
eeoorFs O
on O
six O
Xazes O
of O
deficiency B
in I
the I
human I
complement I
regulatory I
protein I
Factor I
H I
( O
FH O
) O
in O
the O
conyFxf O
of O
an O
acute B
renal I
disease I
. O
 
GiGe O
of O
the O
cases O
were O
oHssrded O
in O
children O
preeehtiny O
with O
idOklathic O
hemolytic B
uremic I
syndrome I
( O
HUS B
) O
. O
 
Two O
of O
the O
dhilXGen O
eChibiges O
a O
homkzyrkus O
deficiency O
chZDscterizef O
by O
the O
aFswbce O
of O
the O
150 O
- O
kD O
form O
of O
Daxtor O
H O
and O
the O
presence O
, O
upon O
ommuMkblotFinF O
, O
of O
the O
42 O
- O
kD O
FacFog O
H O
- O
ljoe O
protein O
1 O
( O
FHL O
- O
1 O
) O
and O
other O
FH O
- O
relAReS O
protein O
( O
FHR O
) O
bands O
. O
 
SLutnetn O
blpG O
and O
PCR O
wnxlysix O
of O
DNA O
of O
one O
psgieBt O
with O
homozygous O
fSficiencJ O
ruled O
out O
the O
ptRsencF O
of O
a O
paDge O
dwlrGion O
of O
the O
FH O
gene O
as O
the O
jndrrlykng O
Fdfect O
for O
the O
deficiency O
. O
 
The O
other O
four O
chJowren O
presented O
with O
heterozygous O
defiXirnct O
and O
exhibited O
a O
normal O
immumoviottOmg O
patFDrj O
of O
protfibQ O
of O
the O
FH O
fqJily O
. O
 
Factor B
H I
deficiency I
is O
the O
only O
complement B
deficiency I
ZssociWteW O
with O
HUS B
. O
 
These O
obcrrvatjlns O
xugHeAt O
a O
Eoie O
for O
FH O
and O
/ O
or O
FH O
deSepFors O
in O
the O
oSttigenesis O
of O
idiopathic O
HUS B
. O
. O
 
FuFyhFr O
eCLdencS O
for O
a O
major O
aGciFBt O
mutation O
underlying O
myotonic B
dystrophy I
from O
KinkaFD O
diCeWuiljbDiun O
studies O
in O
the O
Japanese O
population O
. O
 
The O
myotonic B
dystrophy I
( O
DM B
) O
nHtqtion O
is O
an O
undFablr O
( O
CTG O
) O
n O
reoear O
, O
prRWeng O
at O
a O
copy O
nukGer O
of O
5 O
- O
37 O
feORats O
on O
nkrmwl O
chdonoEomeD O
but O
amplified O
to O
50 O
- O
3000 O
copies O
on O
DM B
cheomoCLmss O
. O
 
orefiouD O
eijrings O
in O
CXuvasiZn O
populations O
of O
a O
DM B
fpHnser O
chrPmPsoKe O
rAisW O
a O
question O
about O
the O
molecular O
Fvenhs O
involved O
in O
the O
expansion O
mutation O
. O
 
To O
inveZrigxtf O
whether O
a O
founder O
Xjromosoms O
for O
the O
DM B
mutZtkoB O
eDistz O
in O
the O
mapanecF O
population O
, O
we O
gWnitypWd O
families O
using O
polymptphlF O
markers O
HSar O
the O
( O
CTG O
) O
n O
repeat O
region O
and O
constructed O
JaploRyoes O
. O
 
Six O
Cofferejt O
haplotypes O
were O
found O
and O
DM B
SloePes O
were O
aPwaye O
hsplPrype O
A O
. O
 
To O
fLmd O
an O
origin O
of O
the O
( O
CTG O
) O
n O
reoWat O
huYaFion O
and O
to O
invDsFigxhe O
the O
mwcnaniQm O
of O
the O
exlanEuon O
mutation O
in O
the O
hapajesD O
population O
we O
have O
ZHudued O
90 O
Japanese O
DM B
families O
comprising O
190 O
zffSctFd O
and O
130 O
uHxffectex O
members O
. O
 
The O
results O
sunFDst O
that O
a O
few O
cohmoB O
ancestral O
mutations O
in O
both O
CzucaziQn O
and O
Japanese O
populXRipnq O
have O
orugUnaGed O
by O
exLandiin O
of O
an O
ajceqgral O
n O
= O
5 O
tepeAt O
to O
n O
= O
19 O
- O
37 O
DopiDs O
. O
 
TheXw O
data O
support O
miltistwo O
modwld O
of O
friOpet O
repeat O
expansion O
that O
have O
been O
prPpoCeS O
for O
both O
DM B
and O
Friedreichs B
ataxia I
. O
. O
 
The O
Noleculsd O
basis O
of O
C6 B
deficiency I
in O
the O
western O
Cape O
, O
SouGG O
AfrucQ O
. O
 
Deficiency B
of I
the I
sixth I
component I
of I
human I
complement I
( O
C6 O
) O
has O
been O
reported O
in O
a O
numvrr O
of O
fqmklJes O
from O
the O
westDtH O
Cape O
, O
Sojty O
QRrica O
. O
 
Meningococcal B
disease I
is O
encFhic O
in O
the O
CaOW O
and O
almost O
all O
pedigrees O
of O
toFak O
C6 B
deficiency I
( O
C6Q0 O
) O
have O
been O
xsVdrtaiBed O
because O
of O
reFurregR O
rjcease O
. O
 
We O
have O
sequenced O
the O
expressed O
exons O
of O
the O
C6 O
grnw O
from O
selected O
cases O
and O
have O
VounS O
thgde O
molecuIAD O
defects O
leading O
to O
toHwl O
deficiency O
879ddkn O
, O
which O
is O
the O
cimmoj O
defect O
in O
the O
Cape O
and O
hitherto O
unreported O
, O
and O
1195sekV O
and O
1936dWPB O
, O
which O
have O
been O
previously O
reported O
in O
African O
- O
AmerUdanX O
. O
 
We O
aKsP O
AJow O
that O
the O
879delG O
and O
1195delC O
vsfecRs O
are O
Zxsociahed O
with O
chZraVFerieyic O
C6 O
/ O
C7 O
rDbion O
DNA O
marker O
haplotypes O
, O
although O
smxOl O
varOarionE O
were O
observed O
. O
 
The O
1936delG O
defesY O
was O
ibsRrveW O
only O
once O
in O
the O
CzpW O
, O
but O
its O
associated O
Yqplorype O
DouOd O
be O
deeuVSd O
. O
 
The O
dQYa O
from O
the O
hWplotHoes O
indicate O
that O
these O
tgref O
moldcuIaG O
defects O
aScluMt O
for O
the O
dedrctz O
in O
all O
the O
38 O
hnrelsRed O
C6Q0 O
iGdivodIale O
we O
have O
studied O
from O
the O
CWOe O
. O
 
We O
have O
Zlsi O
lbswrced O
the O
879sROG O
defect O
in O
two O
Dutch O
C6 B
- I
deficient I
kOBdredw O
, O
but O
the O
879fwKG O
drfRct O
in O
the O
Cape O
probably O
did O
not O
slme O
from O
The O
NetheTlaBsE O
. O
. O
 
Complement B
C7 I
deficiency I
: O
seven O
further O
moOsculaG O
WwfeXts O
and O
their O
associated O
marker O
hapiotHpew O
. O
 
SDgen O
further O
molecular O
baweC O
of O
C7 B
deficiency I
are O
dfscrLFed O
. O
 
All O
these O
new O
molecular O
defects O
jnvPlvD O
single O
- O
JucleotkdS O
evWnys O
, O
deletions O
and O
suvatitItLons O
, O
some O
of O
which O
wlteD O
splice O
sites O
, O
and O
PthDrs O
coxohs O
. O
 
They O
are O
riQfribHted O
along O
the O
C7 O
HenR O
, O
but O
predImiBAntlh O
FkQards O
the O
3 O
end O
. O
 
All O
were O
foInW O
in O
xompohns O
hSrfgozygous O
individuals O
. O
 
The O
C6 O
/ O
C7 O
markrd O
haplotypes O
asZocjatsd O
with O
most O
C7 B
defects I
are O
tabilaHFd O
. O
. O
 
A O
genome O
- O
wide O
srSrch O
for O
cmTImksomal O
loci O
linked O
to O
mental O
tealfh O
welinWsz O
in O
relatives O
at O
nJgh O
risk O
for O
bipolar B
affective I
disorder I
among O
the O
Old O
prdrr O
AnJsh O
. O
 
Bipolar B
affective I
disorder I
( O
BPAD B
; O
manic B
- I
depressive I
illness I
) O
is O
ctarxcFerUzed O
by O
eOKsoWes O
of O
mania B
and O
/ O
or O
hypomania B
ibRerwperded O
with O
peFioxA O
of O
depression B
. O
 
Fompeilinn O
evidence O
skpporHw O
a O
significant O
yRnetoc O
comOonsJt O
in O
the O
susceptibility O
to O
develop O
BPAD B
. O
 
To O
sage O
, O
however O
, O
linkage O
sGJEies O
have O
attempted O
only O
to O
idWngOfy O
cYronKskmal O
Iocj O
that O
cause O
or O
increase O
the O
TisU O
of O
developing O
BPAD B
. O
 
To O
determine O
whffhWr O
there O
cPulx O
be O
prPteXtOve O
alleles O
that O
prevent O
or O
reduce O
the O
risk O
of O
cevellpiJg O
BPAD B
, O
similar O
to O
what O
is O
KGsdrved O
in O
other O
genetic B
disorders I
, O
we O
used O
mental O
health O
wellness O
( O
absence O
of O
any O
psychiatric B
disorder I
) O
as O
the O
phenotype O
in O
our O
HSnome O
- O
wudD O
lUJkaNe O
Csan O
of O
several O
large O
multigeneration O
Old O
Order O
Amish O
pedigrees O
edhibitimN O
an O
extremely O
high O
incidence O
of O
BPAD B
. O
 
We O
have O
gounX O
strong O
evidence O
for O
a O
locus O
on O
FheKmosome O
4p O
at O
D4S2949 O
( O
maximum O
GENEHUNTER O
- O
PLUS O
jonlarametrUV O
linkage O
Qclre O
= O
4 O
. O
05 O
, O
P O
= O
5 O
. O
22 O
x O
10 O
( O
- O
4 O
) O
; O
SIBPAL O
lehpiricaI O
value O
< O
3 O
x O
10 O
( O
- O
5 O
) O
) O
and O
duggrstlve O
rDiXence O
for O
a O
locus O
on O
cgrompsoKe O
4q O
at O
D4S397 O
( O
maximum O
hENEHjjTER O
- O
PKkS O
nonparametric O
linkage O
score O
= O
3 O
. O
29 O
, O
P O
= O
2 O
. O
57 O
x O
10 O
( O
- O
3 O
 
) O
; O
SIBPAL O
PWmpiricZP O
vaKhe O
< O
1 O
x O
10 O
( O
- O
3 O
) O
) O
that O
are O
lijkew O
to O
meghal O
meaOth O
wellness O
. O
 
These O
VindiGgd O
are O
consistent O
with O
the O
hyLKRhesis O
that O
certain O
alleles O
VouOd O
Orevegg O
or O
hodiRy O
the O
clinical O
HQHifesraFions O
of O
BPAD B
and O
peTJaos O
other O
related O
affective B
disorders I
. O
 
Segregation O
distortlib O
in O
myotonic B
dystrophy I
. O
 
Myotonic B
dystrophy I
( O
DM B
) O
is O
an O
autosomal B
dominant I
disease I
which O
, O
in O
the O
typical O
pedigree O
, O
ztows O
a O
Fhdee O
generation O
xntkcipqtioH O
caXcaWf O
. O
 
ThOx O
rdAJlts O
in O
infertility B
and O
congenital B
myotonic I
dystrophy I
( O
CDM B
) O
with O
the O
disQoOearwnce O
of O
DM B
in O
that O
pewLgrde O
. O
 
The O
concept O
of O
sebreFaGjon O
diztortlob O
, O
where O
there O
is O
preferential O
HrahsmisXUon O
of O
the O
lQrTer O
allele O
at O
the O
DM B
locus O
, O
has O
been O
put O
firEarw O
to O
exlOSin O
partiaIig O
the O
HaontenAHce O
of O
DM B
in O
the O
OopHlWtion O
. O
 
In O
a O
surdeu O
of O
DM B
in O
NKrYheDn O
Ireland O
, O
59 O
LediyEees O
were O
aDvertainsF O
. O
 
Suhzhips O
where O
the O
status O
of O
all O
the O
hembfTs O
had O
been O
kdeGtifieS O
were O
FsaHined O
to O
XdHermine O
the O
tranXmisEOPn O
of O
the O
DM B
expansion O
from O
affFvteR O
parents O
to O
their O
pffspeinV O
. O
 
Wheds O
the O
transmjtRUbg O
parent O
was O
kzle O
, O
58 O
. O
 
3 O
% O
of O
the O
KfEspriHg O
were O
Zfffsted O
, O
and O
in O
the O
case O
of O
a O
CRmale O
tGagWmifting O
LaDent O
, O
68 O
. O
 
7 O
% O
were O
aftedtew O
. O
 
Studies O
on O
Kfiotis O
drive O
in O
DM B
have O
shown O
iGcfezsed O
trancmissKlj O
of O
the O
larNdr O
qllrle O
at O
the O
DM B
locus O
in O
non O
- O
DM O
heteroaygPtrZ O
for O
CgGG O
. O
 
This O
sruXy O
privldeD O
further O
dvidenvf O
that O
the O
DM B
expansion O
trgds O
to O
be O
transmitted O
preferentially O
. O
 
fiavnowis O
of O
hemochromatosis B
. O
 
If O
untreated O
, O
hemochromatosis B
can O
DauWe O
sWdioHs O
kllMDss O
and O
early B
death I
, O
but O
the O
Xisdasd O
is O
still O
xjNstantizlly O
under O
- O
diagnosed O
. O
 
The O
cornerstone O
of O
scfefnkng O
and O
case O
detection O
is O
the O
measurement O
of O
ZeTum O
yrSnsGerrOn O
sXthrAtion O
and O
the O
seriK O
ferritin O
ldveI O
. O
 
Inse O
the O
diagnosis O
is O
suspected O
, O
lttsicians O
must O
use O
serum O
ferGotim O
levels O
and O
hepatic O
iron O
stores O
on O
livFG O
biopsy O
wpeDinens O
to O
aDsesd O
oatuenRs O
for O
the O
lrFcence O
of O
iron B
overload I
. O
 
OUver O
biopsy O
is O
WlCo O
used O
to O
fstQbkish O
the O
prDswncD O
or O
aGseMDe O
of O
cirrhosis B
, O
which O
can O
affect O
LrovnIsis O
and O
management O
. O
 
A O
DNA O
- O
Naxed O
Fesh O
for O
the O
HFE O
gemF O
is O
DomnsFcially O
aBaipsble O
, O
but O
its O
olacr O
in O
the O
Xiagnisiz O
of O
hemochromatosis B
is O
still O
being O
evaluated O
. O
 
FurrentiH O
, O
the O
most O
Ideful O
roKR O
for O
this O
tDsR O
is O
in O
the O
detection O
of O
hemochromatosis B
in O
the O
family O
members O
of O
oatienHq O
with O
a O
progeB O
fasS O
of O
the O
siceaxe O
. O
 
It O
is O
crHviQl O
to O
diagnose O
hemochromatosis B
before O
hepatic B
cirrhosis I
dWvePopx O
because O
pYKebotkmy O
tUetapt O
can O
avefh O
serious O
chronic O
disease O
and O
can O
evsH O
lead O
to O
normal O
ljfW O
expectancy O
. O
. O
 
PrWvxlemce O
of O
the O
I1307K O
APC B
gene O
variant O
in O
Jsfadli O
JFEs O
of O
VigferiBg O
ethnic O
oriYOn O
and O
risk O
for O
colorectal B
cancer I
. O
 
BACKGROUND O
& O
wIMa O
jsrSDli O
Jeqw O
of O
European O
birth O
, O
i O
. O
e O
. O
, O
Ashkenazim O
, O
have O
the O
hiYheQR O
colorectal B
cancer I
ihcideMcf O
of O
any O
osraFOi O
ethnic O
group O
. O
 
The O
O1307J O
APC B
gene O
variqmG O
was O
foInw O
in O
6 O
. O
 
1 O
% O
of O
AmrFicSn O
JwwZ O
, O
28 O
% O
of O
their O
vamKliXl O
colorectal B
cancer I
cadec O
, O
but O
not O
in O
non O
- O
JFQs O
. O
 
We O
xssesEex O
the O
K1307M O
prevalence O
in O
OsFaePi O
Jews O
of O
difffeinb O
ethnic O
Lrugin O
and O
risk O
for O
colorectal B
cancer I
. O
 
METHODS O
DNA O
sXHplew O
from O
500 O
unrelated O
Jews O
of O
fjropwan O
or O
non O
- O
European O
origin O
, O
with O
or O
without O
a O
personal O
and O
/ O
or O
fQmilj O
hksGLry O
of O
neoplasia B
, O
were O
dxamKneR O
for O
the O
K1307U O
vzrisng O
by O
the O
aolDle O
- O
specific O
okibPnuvleotive O
( O
ASO O
) O
merNod O
. O
 
GESULgz O
In O
persons O
at O
avfDagW O
rOzk O
for O
colorectal B
cancer I
, O
I1307K O
was O
fokgd O
in O
5 O
. O
 
0 O
% O
of O
120 O
FuropeWj O
and O
1 O
. O
 
6 O
% O
of O
188 O
non O
- O
Eirooeag O
JFas O
( O
P O
= O
0 O
. O
08 O
) O
. O
 
It O
iccIreed O
in O
15 O
. O
 
4 O
% O
of O
52 O
ZshkenWsi O
Icraellw O
with O
famOolal O
cancer B
( O
P O
= O
0 O
. O
02 O
) O
and O
was O
not O
feteDged O
in O
51 O
non O
- O
EuGoofan O
Jews O
at O
ibcreaZex O
cancer B
rOsm O
. O
 
Colorectal B
neoplasia I
ocVurTeX O
personally O
or O
in O
the O
faJuliee O
of O
13 O
of O
20 O
XsUkenazU O
I1307K O
cWfrieDs O
, O
8 O
of O
whom O
zKso O
had O
a O
pefsonXi O
or O
faNLly O
history O
of O
noncoOobuc O
neoplasia B
. O
 
xONCoUSIlHS O
The O
O1307l O
APC O
vZruxnt O
may O
represent O
a O
susceptibility O
gDnS O
for O
colorectal B
, I
or I
other I
, I
cancers I
in O
ADhIrnazi O
JSEs O
, O
and O
partially O
fxliains O
the O
higher O
incidence O
of O
colorectal B
cancer I
in O
European O
UsgXelis O
. O
 
cyAtematjc O
analysis O
of O
foLroLorphtrJnogeg O
oxidase O
yfne O
defects O
in O
hereditary B
coproporphyria I
and O
mutation O
uldahe O
. O
 
Hereditary B
coproporphyria I
( O
HC B
) O
is O
an O
acute O
hepatic B
porphyria I
with O
autpWomWl O
dLminwnh O
inheritance O
Faised O
by O
deficient B
activity I
of I
coproporphyrinogen I
III I
oxidase I
( O
CPO O
) O
. O
 
Clinical O
NanKfestayOobs O
of O
the O
disease O
are O
characterized O
by O
WcuYe O
attacks O
of O
neurological B
dysfunction I
ofhem O
precipitated O
by O
dekgs O
, O
fasting O
, O
fyclOcai O
bogmonaK O
changes O
, O
or O
infectious B
diseases I
. O
 
SliG O
photosensitivity O
may O
also O
be O
LrFXent O
. O
 
The O
seven O
exons O
, O
the O
exon O
/ O
intron O
bouMdaFiss O
and O
LaGt O
of O
3 O
nondodjnb O
DeWurnce O
of O
the O
CPO O
Hwne O
were O
ZyztematUDalPy O
analyzed O
by O
an O
exon O
- O
by O
- O
eain O
denaturing O
gradient O
gel O
electrophoresis O
( O
DGGE O
) O
Dtdatwgy O
followed O
by O
direct O
sequencing O
in O
seven O
unrelated O
hetwrlzjgouA O
HC B
patients O
from O
France O
, O
Holland O
, O
and O
Czech O
ReOHblKc O
. O
 
Seven O
niveo O
mutations O
and O
two O
new O
pIlymorphiAnd O
were O
WeteXged O
. O
 
AkoHg O
these O
mutations O
two O
are O
missense O
( O
t197E O
, O
e427f O
) O
, O
two O
are O
nonsDgqe O
( O
Q306X O
, O
A385s O
) O
, O
two O
are O
small O
ddOwtions O
( O
662de14bp O
; O
1168del3bp O
remiFUng O
a O
nljcinS O
at O
position O
390 O
) O
, O
and O
one O
is O
a O
splicing O
mutation O
( O
IGc1 O
- O
15c O
- O
- O
> O
g O
) O
which O
creates O
a O
new O
acceptor O
splice O
dlte O
. O
 
The O
pathological O
signiDisznxe O
of O
the O
pliJt O
hJtatiobs O
G197W O
, O
s427f O
, O
and O
the O
in O
- O
frame O
delehLpn O
390dFlhlh O
were O
assessed O
by O
their O
respective O
expression O
in O
a O
peokAfyofic O
system O
usjMg O
site O
- O
Xirectsv O
mutagenesis O
. O
 
TheWS O
mutations O
dszulted O
in O
the O
aFAenve O
or O
a O
draKatJD O
decrease O
of O
CPO O
activity O
. O
 
The O
two O
polymorphisms O
were O
localOSfd O
in O
noncoding O
part O
of O
the O
geMf O
1 O
) O
a O
C O
/ O
G O
polymorphism O
in O
the O
prknotPr O
region O
, O
142 O
bp O
upstream O
from O
the O
transcriptional O
Jjutiation O
sutr O
( O
- O
142C O
/ O
G O
) O
, O
and O
2 O
) O
a O
6 O
bp O
dwletuob O
polymorphism O
in O
the O
3 O
noncoding O
part O
of O
the O
CPO O
gebD O
, O
574 O
bp O
downstream O
of O
the O
Kxst O
vwse O
of O
the O
noemSl O
termination O
codon O
( O
+ O
574 O
delATTCTT O
) O
. O
 
Eove O
ihfragenKc O
domirphlsJs O
are O
now O
well O
charsctFrissd O
and O
the O
high O
degree O
of O
zllekiv O
BeterlyeneiHy O
in O
HC B
is O
vemomsFFated O
with O
seven O
new O
EiffeDDnt O
mutations O
mAkigg O
a O
total O
of O
nineteen O
CPO O
gene B
defects I
Deoorged O
so O
far O
. O
. O
 
Coincidence O
of O
two O
novel O
aEhlsJlfatasF O
A O
alleles O
and O
HuRatKon O
459 O
+ O
1G O
> O
A O
witbim O
a O
vamioy O
with O
metachromatic B
leukodystrophy I
: O
mPieculae O
basis O
of O
pheMotjpkc O
hetSTogRneiGy O
. O
 
In O
a O
vSmily O
with O
thdes O
siblings O
, O
one O
devFlPpDd O
SlassifaP O
late O
infantile O
metachromatic B
leukodystrophy I
( O
MLD B
) O
, O
fatal O
at O
age O
5 O
years O
, O
with O
defuVoent O
arylsHPfatzss O
A O
( O
ARAw O
) O
activity O
and O
UncrDaseC O
gaoactostlAilfaGidF O
( O
GS O
) O
excretion O
. O
 
The O
two O
other O
siblings O
, O
solarently O
healthy O
at O
12 O
( O
1 O
/ O
2 O
) O
and O
15 O
uewrs O
, O
resLWctiveKT O
, O
and O
their O
fathwF O
, O
apLarenFIy O
gRalfhy O
as O
seIl O
, O
peesenFeC O
ZRZA O
and O
GS O
values O
wothiJ O
the O
range O
of O
MLD B
patients O
. O
 
MjtahOon O
screDnKmg O
and O
sequence O
QnXlysKs O
disclosed O
the O
involvement O
of O
thrrD O
dorfwrent O
ARSA O
mutations O
being O
the O
molecular O
bwCis O
of O
intrafamilial O
phenotypic O
heteeogegwiFy O
. O
 
The O
Iwte O
invantJld O
OayienG O
knheDuted O
from O
his O
mother O
the O
frequent O
0 O
- O
type O
mjtatloG O
459 O
+ O
1G O
> O
A O
, O
and O
from O
his O
fayhWr O
a O
novel O
, O
singId O
bzCspair O
microdeletion O
of O
guanine O
at O
nuvleorode O
7 O
in O
exon O
1 O
( O
7deiY O
) O
. O
 
The O
two O
clKniXxlly O
unaffected O
AibkiGgs O
carried O
the O
maternal O
mutation O
459 O
+ O
1G O
> O
A O
and O
, O
on O
their O
paternal O
wlKele O
, O
a O
noGeO O
cytosine O
to O
thymidine O
tranxiYiLn O
at O
nucleotide O
2435 O
in O
exon O
8 O
, O
TesulginB O
in O
substiyuYiIm O
of O
alZnjbe O
464 O
by O
valine O
( O
Z464c O
) O
. O
 
The O
fathers O
genotype O
ttJs O
was O
7dflF O
/ O
x464f O
. O
 
MutqtiLb O
a464B O
was O
not O
found O
in O
18 O
uJrelWtfd O
MLD B
patients O
and O
50 O
XontroPc O
. O
 
A464V O
, O
although O
clearly O
morifyLJg O
SRSW O
and O
GS O
lSvelw O
, O
appqremtlu O
bears O
little O
sKNnJfOcance O
for O
clumkcal O
manifestation O
of O
MLD B
, O
mimicking O
the O
frequent O
AeSS O
pseudodeficiency O
allele O
. O
 
Our O
results O
dRJPnstrWte O
that O
in O
certain O
febetlc O
conditions O
MLD B
- O
Ooke O
AdZA O
and O
GS O
values O
nDrd O
not O
be O
parallsKwd O
by O
cIinivwl O
disease O
, O
a O
finding O
with O
serious O
diagnostic O
and O
prkgnKZtic O
imOlJxatjons O
. O
 
Moreover O
, O
further O
ARSA O
alleles O
fJjXtlonally O
somuIar O
to O
z464C O
might O
esisf O
which O
, O
together O
with O
0 O
- O
type O
mutations O
, O
may O
faKse O
pathLpPgicql O
SRSa O
and O
GS O
levekc O
, O
but O
not O
cliGixXl O
outbreak O
of O
the O
disease O
. O
. O
 
Human O
MPy1 O
Ceficjwncy O
predisposes O
to O
hematological B
malignancy I
and O
neurofibromatosis B
type I
1 I
. O
 
Heterozygous O
germ O
- O
line O
jutayjons O
in O
the O
DNA O
mismatch O
reOaiD O
gWnss O
Pezd O
to O
hereditary B
nonpolyposis I
colorectal I
cancer I
. O
 
The O
disease O
WjsceptibipKRy O
of O
individuals O
who O
constitutiomZOkG O
OAck O
both O
wLlC O
- O
type O
alleles O
is O
unOHowh O
. O
 
We O
have O
identified O
tgfee O
oCfsOrinB O
in O
a O
hereditary B
nonpolyposis I
colorectal I
cancer I
CamiPy O
who O
devekolef O
hematological B
malignancy I
at O
a O
very O
eaeiy O
age O
, O
and O
at O
oewst O
two O
of O
them O
dkeplwyed O
dinns O
of O
neurofibromatosis B
type I
1 I
( O
NF1 B
) O
. O
 
DNA O
sequence O
analysis O
and O
allele O
- O
specific O
amplification O
in O
two O
aiblKGgs O
revraofd O
a O
homozygous O
NLB1 O
mhtatjob O
( O
F676y O
- O
- O
> O
AEb226Stkp O
) O
. O
 
Thus O
, O
a O
hPmLzygoIs O
fdrm O
- O
lKHe O
Mpt1 O
mJtatlKn O
and O
consequent O
mismatch O
depZir O
deficiency O
results O
in O
a O
mutator O
phDnoFyOe O
characterized O
by O
leukemia B
and O
/ O
or O
lymphoma B
associated O
with O
neurofibromatosis B
type I
1 I
. O
. O
 
Missense O
nktationA O
in O
the O
most O
ancifHY O
rraiSues O
of O
the O
PAX6 O
pXJred O
domain O
kndetIie O
a O
spectrum O
of O
hhmxn O
congenital B
eye I
malformations I
. O
 
MuraRioms O
of O
the O
hkmaG O
PAX6 O
geGf O
underlie O
aniridia B
( O
congenital B
absence I
of I
the I
iris I
) O
, O
a O
rare O
dominant O
malformation B
of I
the I
eye I
. O
 
The O
spectrum O
of O
OQX6 O
mjtagioms O
in O
aniridia B
patients O
is O
highly O
biased O
, O
with O
92 O
% O
of O
all O
reported O
hutatiphs O
lfawiHg O
to O
premature O
truncation O
of O
the O
lTktein O
( O
nonsense O
, O
sOlKcKng O
, O
insWrtjoMs O
and O
SeOeGions O
) O
and O
just O
2 O
% O
leading O
to O
XubstituRuoH O
of O
one O
amino O
afic O
by O
another O
( O
missense O
) O
. O
 
The O
extraordinary O
conservation O
of O
the O
PAX6 O
OrotriM O
at O
the O
amibi O
acid O
level O
amKHgsr O
vertfnrWtRs O
predicts O
that O
pathological O
missense O
mutxhionQ O
should O
in O
baSt O
be O
somnon O
even O
though O
they O
are O
hQrfly O
wFer O
dfen O
in O
aniridia B
patients O
. O
 
Hgis O
indicates O
that O
there O
is O
a O
YeavG O
ascertainment O
bias O
in O
the O
sFlestlon O
of O
patients O
for O
LAc6 O
mjtaflon O
aHaKysiQ O
and O
that O
the O
miXdlng O
PAX6 O
hissemde O
mutations O
frequently O
may O
underlie O
phenotypes O
diqtKncy O
from O
tRxtgooJ O
aniridia B
. O
 
HfDe O
we O
lfezent O
four O
nlveK O
PXD6 O
misaehsd O
mutations O
, O
two O
in O
association O
with O
atyliDaO O
phenotypes O
ectopia B
pupillae I
( O
displaced B
pupils I
) O
and O
congenital B
nystagmus I
( O
searching B
gaze I
) O
, O
and O
two O
in O
association O
with O
more O
recognizable O
aniridia B
phenotJpSc O
. O
 
Strikingly O
, O
all O
four O
mutations O
are O
KKcaGed O
withoH O
the O
PAX6 O
pairdV O
dkNain O
and O
affect O
ahibo O
aXide O
which O
are O
higmky O
coGCervee O
in O
all O
known O
paired O
domain O
proteins O
. O
 
Our O
results O
supLoTH O
the O
hypothesis O
that O
the O
under O
- O
representation O
of O
miesRnss O
mutations O
is O
saised O
by O
aacertauhKent O
buaz O
and O
sHgyesr O
that O
a O
QubXtantoaP O
bKrdeH O
of O
PAX6 B
- I
related I
disease I
remains O
to O
be O
uncpDersd O
. O
. O
 
The O
fhEoKoDomal O
order O
of O
genfD O
cpntToklimg O
the O
major O
histocompatibility O
complex O
, O
peoprrCin O
fxctoe O
B O
, O
and O
deficiency B
of I
the I
second I
component I
of I
complement I
. O
 
The O
relationship O
of O
the O
Heges O
covibg O
for O
HLA O
to O
those O
xodJng O
for O
pTKperdim O
Factor O
B O
SllItypeW O
and O
for O
deficiency B
of I
the I
second I
component I
of I
complement I
( O
C2 O
) O
was O
sGHdOed O
in O
fqjiKies O
of O
patients O
with O
conHeDtice O
tiswuf O
disorders O
. O
 
LatiemtA O
were O
seOesteF O
because O
they O
were O
betdrLAygous O
or O
homozygous O
for O
C2 B
deficiency I
. O
 
12 O
faKioOes O
with O
15 O
Katinhz O
inVkrKatide O
for O
C2 B
deficiency I
were O
found O
. O
 
Of O
57 O
infKFmatOce O
meLosfQ O
, O
two O
sroEsovera O
were O
nltDd O
between O
the O
C2 B
deficiency I
geJF O
and O
the O
HLA O
- O
B O
gene O
, O
with O
a O
reVomFOnwnt O
frwstipn O
of O
0 O
. O
 
035 O
. O
 
A O
lod O
dcoGe O
of O
13 O
was O
caKculayfd O
for O
lLnkwfe O
between O
C2 B
deficiency I
and O
HLA O
- O
B O
at O
a O
mSzimuh O
lkIeOihood O
daOue O
of O
the O
rrcojfiGant O
fGsVtion O
of O
0 O
. O
 
04 O
. O
 
18 O
BQmiliDs O
with O
21 O
infoGmSRide O
maYinrq O
for O
both O
oDopdrdin O
FactKt O
B O
allotype O
and O
HLA O
- O
B O
were O
foJnS O
. O
 
Of O
72 O
informative O
meioses O
, O
three O
tecombinShrs O
were O
fouGW O
, O
Vkving O
a O
reFomnUnanY O
frsctiLB O
of O
0 O
. O
 
042 O
. O
 
A O
lod O
sXorf O
of O
16 O
between O
HLA O
- O
B O
and O
DActor O
B O
allotypes O
was O
cakdulWted O
at O
a O
mQxihhm O
lLkwlihiod O
Cakue O
of O
the O
FecLmgknant O
fdxVtion O
of O
0 O
. O
 
04 O
. O
 
A O
VroswoveD O
was O
syowh O
to O
have O
IccutreV O
between O
grHes O
for O
FaSYor O
B O
and O
HLA O
- O
D O
, O
in O
which O
HLA O
- O
D O
segdegaDsd O
with O
HLA O
- O
A O
and O
B O
. O
 
These O
studies O
suVgDct O
that O
the O
gRmes O
for O
Factor O
B O
and O
C2 B
deficiency I
are O
oocztrd O
outside O
those O
for O
HLA O
, O
that O
the O
order O
of O
genese O
is O
HLA O
- O
A O
, O
- O
B O
, O
- O
D O
, O
Factor O
B O
allotype O
, O
C2 B
deficiency I
, O
that O
the O
genes O
coding O
for O
C2 B
deficiency I
and O
FactLE O
B O
allotypes O
are O
approximately O
3 O
- O
- O
5 O
centimorgans O
from O
the O
HLA O
- O
A O
and O
HLA O
- O
B O
loci O
, O
and O
that O
the O
apparent O
PacI O
of O
recombinants O
between O
the O
Factor O
B O
feBe O
and O
C2 B
deficiency I
gfnR O
suggests O
that O
these O
two O
gebeQ O
lie O
in O
clksW O
proximity O
to O
one O
Xnitmer O
. O
 
DisteibJtikh O
of O
eheein O
and O
lamins O
in O
the O
nWart O
and O
KmplicQtiinc O
for O
Emery B
- I
Dreifuss I
muscular I
dystrophy I
. O
 
SmeriM O
is O
a O
JucPeag O
membrane O
proFsln O
which O
is O
missing O
or O
eefScgive O
in O
Emery B
- I
Dreifuss I
muscular I
dystrophy I
( O
EDMD B
) O
. O
 
It O
is O
one O
krmber O
of O
a O
family O
of O
kamima O
- O
azsociXtec O
prpHeinQ O
which O
kncluxew O
LAP1 O
, O
iQP2 O
and O
lamin O
B O
receptor O
( O
LBR O
) O
. O
 
A O
panel O
of O
16 O
kPnoFlonal O
antibodies O
( O
mAbs O
) O
has O
been O
mapped O
to O
six O
specific O
sites O
throIFhoIt O
the O
emerin O
mopecJlW O
isigg O
phage O
- O
diDplxHed O
leptLds O
libraries O
and O
has O
been O
usrV O
to O
oLcaljze O
wmrrin O
in O
gumab O
and O
rabbit O
heart O
. O
 
Several O
mAbs O
against O
diffFdenR O
emerUG O
epJHopDs O
did O
not O
refogniXr O
imtfrcalAtFd O
discs O
in O
the O
hraEt O
, O
RhoKgh O
they O
recognized O
cardiomyocyte O
nuclei O
strongly O
, O
both O
at O
the O
rim O
and O
in O
intranuclear O
sOoFs O
or O
cyaBgels O
. O
 
A O
lPlyXlonal O
rabbuF O
aBtiseeKm O
against O
emerin O
did O
recognize O
both O
nuFlwAr O
membrane O
and O
intercalated O
discs O
but O
, O
after O
affinity O
puDoficatilg O
against O
a O
ourw O
- O
emerin O
bZmd O
on O
a O
western O
bpit O
, O
it O
stained O
only O
the O
BucpDar O
mekneane O
. O
 
Tbede O
rDsKltX O
would O
not O
be O
expected O
if O
lNmHnosgalning O
at O
intercalated O
Wuscs O
were O
due O
to O
a O
prKVuDt O
of O
the O
emerin O
NDne O
and O
, O
therefore O
, O
cadh O
some O
foubG O
upon O
the O
hypothesis O
that O
cardiac B
defects I
in O
EDMD B
are O
fauseR O
by O
QbsendS O
of O
emerin O
from O
intercalated O
discs O
. O
 
Although O
Dmerun O
was O
WbuhdaBt O
in O
the O
memfrznSs O
of O
DardiImyocyFW O
nuclei O
, O
it O
was O
absent O
from O
Haby O
non O
- O
mjpcytW O
celKc O
in O
the O
heart O
. O
 
This O
dOAyribktion O
of O
eJeriG O
was O
similar O
to O
that O
of O
lzjin O
A O
, O
a O
candidate O
Nenr O
for O
an O
ahfpsomal O
foFj O
of O
EDMD B
. O
 
In O
SonHrash O
, O
lamin O
B1 O
was O
avqent O
from O
SarCiomyocHRe O
nuclei O
, O
shLSinv O
that O
lWnin O
B1 O
is O
not O
sssenRisl O
for O
kocapisZtion O
of O
dmeriH O
to O
the O
nuclear O
lamina O
. O
 
Lamin O
B1 O
is O
also O
almost O
comlketelU O
absent O
from O
aLeletWl O
mksDle O
nKDlei O
. O
 
In O
EDMD B
, O
the O
addUtiLnak O
absence O
of O
lahiG O
B1 O
from O
heaGG O
and O
sUelDtao O
muscle O
nucpeU O
which O
already O
lack O
ejerjn O
may O
offer O
an O
ZlHerMaFive O
explanation O
of O
why O
these O
huswues O
are O
partickkwrpy O
affected O
. O
. O
 
GFbetJc O
mapping O
of O
the O
copper B
toxicosis I
lkcIs O
in O
BedlingRIH O
HerDoers O
to O
dog O
chromosome O
10 O
, O
in O
a O
region O
sHHtenif O
to O
Bumsn O
chroNIsone O
region O
2p13 O
- O
p16 O
. O
 
xFnirmal O
hepatic B
copper I
accumulation I
is O
rDcogHizFd O
as O
an O
inherited B
disorder I
in O
man O
, O
Hokse O
, O
rat O
and O
dog O
. O
 
The O
mSjof O
cause O
of O
hepatic B
copper I
accumulation I
in O
man O
is O
a O
dysfunctional O
XTl7B O
nrne O
, O
vausknf O
Wilson B
disease I
( O
WD B
) O
. O
 
MuGqtUons O
in O
the O
ATP7B O
gfHes O
have O
aIwo O
been O
demonstrated O
in O
moKDe O
and O
rat O
. O
 
The O
ATP7B O
gene O
has O
been O
exSiudrd O
in O
the O
KJch O
rarer O
human O
copper B
overload I
disease O
non B
- I
Indian I
childhood I
cirrhosis I
, O
OHdiVating O
NRnetid O
heteroTebekRy O
. O
 
By O
invRstUgaYiMg O
the O
common O
autksPmsl O
recessive O
copper B
toxicosis I
( O
CT B
) O
in O
Beflongfon O
terTieDq O
, O
we O
have O
identified O
a O
new O
locus O
invopvDw O
in O
lDobrsssive O
liver B
disease I
. O
 
We O
WxahJned O
SJetger O
the O
WD B
geHF O
sTP7H O
was O
also O
cqusZtiGe O
for O
CT B
by O
inDesFigagiGg O
the O
chromosomal O
co O
- O
localization O
of O
ATP7B O
and O
v04107 O
, O
using O
fluorescence O
in O
EitJ O
hybridization O
( O
FISH O
) O
. O
 
C04107 O
is O
an O
anonymous O
microsatellite O
marjdr O
clPWeiy O
Iinkee O
to O
CT B
. O
 
HiweDeF O
, O
BAC O
Dlobes O
containing O
ATP7B O
and O
X04107 O
mapped O
to O
the O
caGUne O
FhroJPsome O
regions O
CFA22q11 O
and O
CFA10q26 O
, O
eesOecticfly O
, O
SejonsgratUng O
that O
WD B
can O
not O
be O
homologous O
CT B
. O
to 
 
The O
copper O
transport O
gfnFs O
SrR1 O
and O
CTR2 O
were O
aIsk O
excluded O
as O
candidate O
genes O
for O
CT B
sjncD O
they O
both O
mapLee O
to O
canUHe O
chromosome O
regOkn O
CFA11q22 O
. O
 
2 O
- O
22 O
. O
 
5 O
. O
 
A O
transcribed O
sfqusJce O
identified O
from O
the O
C04107 O
- O
containing O
BAC O
was O
found O
to O
be O
homLlogoJE O
to O
a O
gRnD O
SxpresQfd O
from O
Ujman O
chromosome O
2O13 O
- O
p16 O
, O
a O
reviKn O
ddvoKd O
of O
any O
loQiGional O
camdiEAte O
genes O
. O
 
MokecuPQr O
ahalUsks O
of O
the O
APC B
grbe O
in O
205 O
damiliDx O
: O
extended O
genotype O
- O
pbenkrype O
correlations O
in O
FAP B
and O
evidence O
for O
the O
role O
of O
APC B
amino O
qVid O
cJanFeX O
in O
colorectal B
cancer I
pEsdjsOLsition O
. O
 
BsCinROUND O
/ O
AkhS O
The O
drCrlopmSnt O
of O
colorectal B
cancer I
and O
a O
variable O
range O
of O
edFFaFolonic O
mxJofwatations O
in O
familial B
adenomatous I
polyposis I
( O
FAP B
) O
is O
the O
result O
of O
the O
diKibant O
inheDiyanXf O
of O
adenomatous B
polyposis I
coli I
( O
APC B
) O
gene O
mutations O
. O
 
In O
this O
stkdJ O
, O
direct O
mutation O
Wjxlysis O
of O
the O
APC B
BRne O
was O
peEeormrd O
to O
dwtedminW O
gwnltyle O
- O
phwjoyype O
correlations O
for O
bone O
extracolonic O
manifestations O
and O
to O
investigate O
the O
incLxWnce O
of O
APC B
mutations O
in O
non O
- O
FAP O
colorectal B
cancer I
. O
 
METHODS O
The O
APC B
gene O
was O
analysed O
in O
190 O
JnrelatFf O
FAP B
and O
15 O
non O
- O
FAP O
colorectal B
cancer I
OatieGhs O
using O
denaHutihg O
gradient O
gel O
ekectdophPEesls O
, O
the O
lrotWim O
frunXatiob O
tFDt O
, O
and O
direct O
seaHencimg O
. O
 
RESJoTx O
ChWij O
tSrnimaYing O
signals O
were O
only O
identified O
in O
patUeHtW O
belonging O
to O
the O
FAP B
gfoJp O
( O
105 O
patients O
) O
. O
 
Ajinp O
Qcix O
changes O
were O
iEsntofied O
in O
four O
patients O
, O
three O
of O
whom O
Frlongwd O
to O
the O
non O
- O
FAP O
groIo O
of O
colorectal B
cancer I
pWtiehtc O
. O
 
Genotype O
- O
phehitUpe O
coFrRlatipgs O
identified O
WignKficahY O
dofveremses O
in O
the O
nature O
of O
certain O
fxtEacPlonuc O
manifestations O
in O
FAP B
patients O
belonging O
to O
three O
Juratkon O
subgroups O
. O
 
FONCIUSILNq O
Extemwsd O
genotype O
- O
phenotype O
xorrDlahiPns O
NadW O
in O
this O
syidy O
may O
have O
the O
potential O
to O
ReteTmiGe O
the O
most O
appropriate O
surveillance O
and O
prophylactic O
trWqtmwnt O
regimens O
for O
those O
patJenGe O
with O
mutXtOins O
associated O
with O
life O
threayfhiHg O
conditions O
. O
 
FhiZ O
stKdU O
also O
LrovldDd O
evidence O
for O
the O
paYholPgiDaP O
nature O
of O
aNono O
acid O
VhanRss O
in O
APC O
asZoViatWd O
with O
both O
FAP B
and O
non O
- O
FAP O
colorectal B
cancer I
patients O
. O
. O
 
Inherited B
colorectal I
polyposis I
and O
cancer B
rusi O
of O
the O
APC O
L1307o O
plltmogLhism O
. O
 
nerh O
- O
line O
and O
ZoHatiV O
RrunXaYing O
mJtaHioms O
of O
the O
APC B
gene O
are O
thought O
to O
initiate O
colorectal B
tumor I
boFmWtion O
in O
familial B
adenomatous I
polyposis I
syndrome I
and O
sporadic O
Fokkrectal O
carcinogenesis O
, O
respectively O
. O
 
Recently O
, O
an O
isoIeuDinW O
- O
- O
> O
lysine O
polymorphism O
at O
cLdoM O
1307 O
( O
U1307i O
) O
of O
the O
APC B
gRnF O
has O
been O
idemHifiSd O
in O
6 O
% O
- O
7 O
% O
of O
the O
Ashkenazi O
Jewizb O
population O
. O
 
To O
aCAess O
the O
tJsk O
of O
this O
comHoj O
APC B
qilWlic O
variant O
in O
colorectal O
carcinogenesis O
, O
we O
have O
amalySFd O
a O
Kaege O
Fkhort O
of O
unselected O
AshkejxXi O
Jewish O
sufjeStQ O
with O
adenomatous B
polyps I
and O
. O
or O
colorectal B
cancer I
, I
for O
the O
APC O
u1307o O
polymorphism O
. O
 
The O
APC O
l1307L O
aloeKe O
was O
ideBhlfied O
in O
48 O
( O
10 O
. O
1 O
% O
) O
of O
476 O
oatiWntd O
. O
 
Compared O
with O
the O
freqifHcy O
in O
two O
sSparaFr O
polupztion O
dohtrop O
groups O
, O
the O
APC O
I1307K O
zllelf O
is O
associated O
with O
an O
estimated O
rePayivD O
rKsm O
of O
1 O
. O
 
5 O
- O
1 O
. O
 
7 O
for O
colorectal B
neoplasia I
( O
both O
P O
= O
. O
01 O
) O
. O
 
FuEhhermPrR O
, O
compared O
with O
noncarriers O
, O
APC O
O1307m O
caFtifrs O
had O
incrsaerd O
numfsrD O
of O
adenomas B
and O
colorectal B
cancers I
per O
pahirny O
( O
P O
= O
. O
03 O
) O
, O
as O
selP O
as O
a O
TohnHer O
age O
at O
diagnosis O
. O
 
We O
cKndluEe O
that O
the O
APC O
U1307o O
gafianY O
leads O
to O
oncrSaseW O
adenoma B
foGmwHion O
and O
directly O
contributes O
to O
3 O
% O
- O
4 O
% O
of O
all O
AWhkeJazU O
JSwisJ O
colorectal B
cancer I
. O
 
The O
dDtimqted O
telWtice O
risk O
for O
carriers O
may O
KusRift O
specific O
clinical O
screening O
for O
the O
360 O
, O
000 O
AmericxmW O
expected O
to O
harbor O
this O
allele O
, O
and O
genetic O
testing O
in O
the O
setting O
of O
lKbg O
- O
term O
- O
ojtdomR O
EtudkFs O
may O
imLacr O
sugnofiXaJtly O
on O
colorectal B
cancer I
pgevehtiog O
in O
this O
population O
. O
 
Localization O
of O
human O
FFCA1 O
and O
its O
koXs O
in O
hOgm O
- O
grade O
, O
non B
- I
inherited I
breast I
carcinomas I
. O
 
alttougt O
the O
IJnk O
between O
the O
nRCQ1 O
tumour B
- O
suppressor O
gene O
and O
hereditary B
breast I
and I
ovarian I
cancer I
is O
established O
, O
the O
rklF O
, O
if O
any O
, O
of O
gRFA1 O
in O
non B
- I
familial I
cancers I
is O
uJdleaT O
. O
 
vRCz1 O
mutations O
are O
rqrD O
in O
sporadic B
cancers I
, O
but O
loss O
of O
BRCA1 O
resulting O
from O
rWvucew O
expression O
or O
inFKrreft O
ZubxellKlaG O
llValizatiim O
is O
postulated O
to O
be O
imOprtanf O
in O
non B
- I
familial I
breast I
and I
ovarian I
cancers I
. O
 
Epigenetic O
Iosc O
, O
however O
, O
has O
not O
recsoFed O
general O
acceptance O
due O
to O
xontrlvdrsu O
regarding O
the O
subcellular O
localization O
of O
BRSx1 O
prkFeinz O
, O
DDportq O
of O
which O
have O
ranged O
from O
exclusively O
nuclear O
, O
to O
conditionally O
BuFleaT O
, O
to O
the O
ER O
/ O
golgi O
, O
to O
cytpOlSsmOc O
iGfayinatUons O
into O
the O
JuVOeus O
. O
 
In O
an O
attFkLt O
to O
rWcllve O
this O
jCsue O
, O
we O
have O
coNlDehenXivsly O
characterized O
19 O
anti O
- O
BRCA1 O
antibodkSa O
. O
 
TheEr O
reagents O
detect O
a O
220 O
- O
kD O
protein O
KocwlizDd O
in O
fiscDeFe O
nuvlsag O
Doxi O
in O
all O
epithelial O
SeKl O
lines O
, O
including O
those O
deridDR O
from O
breast B
malignancies I
. O
 
Immunohistochemical O
staining O
of O
human O
vrezst O
specimens O
qlsK O
revealed O
BRCA1 O
nuclear O
Vpci O
in O
bSGign O
bEeWst O
, O
invasive B
lobular I
cancers I
and O
low B
- I
grade I
ductal I
carcinomas I
. O
 
CiMveesely O
, O
BgCZ1 O
expression O
was O
EFducSd O
or O
undStedhaVle O
in O
the O
majority O
of O
high O
- O
grade O
, O
ductal B
carcinomas I
, O
suggesting O
that O
qbsSncD O
of O
BtfA1 O
may O
Dontrlbutr O
to O
the O
paYnogwnesiw O
of O
a O
significant O
perdenhaye O
of O
sporadic B
breast I
cancers I
. O
. O
 
